No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1a1cA_, 1.0000, 0.00, 1.000, 105, 105, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(- (CH2)3-CYCLOPENTYL))
2, d1a1bA_, 0.9981, 0.16, 1.000, 105, 105, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(NN- DIPENTYL AMINE)
3, d1a08A_, 0.9962, 0.23, 1.000, 105, 105, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR- GLU-(NN-DIPENTYL AMINE)
4, d1a09A_, 0.9927, 0.33, 1.000, 106, 105, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU- (NN-DIPENTYL AMINE)
5, d1a07A_, 0.9908, 0.37, 1.000, 105, 105, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(NN- DIPENTYL AMINE)
6, d1a1aA_, 0.9891, 0.40, 0.990, 106, 105, C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(NN-DIPENTYL AMINE)
7, d1a1eA_, 0.9867, 0.23, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3- BUTYLPIPERIDINE)
8, d1a1bB_, 0.9783, 0.42, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(NN- DIPENTYL AMINE)
9, d1a1eB_, 0.9762, 0.46, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3- BUTYLPIPERIDINE)
10, d1a1cB_, 0.9759, 0.47, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(- (CH2)3-CYCLOPENTYL))
11, d1a08B_, 0.9736, 0.51, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR- GLU-(NN-DIPENTYL AMINE)
12, d1a07B_, 0.9732, 0.51, 1.000, 104, 104, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(NN- DIPENTYL AMINE)
13, d4f5bA_, 0.9617, 0.82, 0.971, 108, 105, TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHOTYROSINE
14, d4f5aA_, 0.9605, 0.83, 0.971, 108, 105, TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHATE ION
15, d4f59A_, 0.9596, 0.84, 0.971, 108, 105, TRIPLE MUTANT SRC SH2 DOMAIN
16, d1o4dA_, 0.9585, 0.84, 1.000, 105, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262.
17, d1o4eA_, 0.9576, 0.85, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299.
18, d1o46A_, 0.9570, 0.86, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395.
19, d1o4pA_, 0.9569, 0.86, 1.000, 105, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791.
20, d1o4oA_, 0.9558, 0.87, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE.
21, d1o42A_, 0.9554, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843.
22, d1o4hA_, 0.9552, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072.
23, d1o4mA_, 0.9549, 0.88, 1.000, 105, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID.
24, d1o45A_, 0.9549, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687.
25, d1o4rA_, 0.9548, 0.90, 1.000, 105, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783.
26, d1o4jA_, 0.9545, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24.
27, d1o4kA_, 0.9544, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN.
28, d1o49A_, 0.9543, 0.89, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.
29, d1o4nA_, 0.9541, 0.88, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID.
30, d1o4iA_, 0.9540, 0.89, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219.
31, d1o41A_, 0.9539, 0.89, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300.
32, d1o43A_, 0.9538, 0.89, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129.
33, d1o44A_, 0.9528, 0.90, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85052
34, d1o4qA_, 0.9526, 0.89, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256.
35, d1o4lA_, 0.9522, 0.92, 1.000, 105, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2.
36, d1o47A_, 0.9519, 0.91, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209.
37, d1o48A_, 0.9508, 0.92, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.
38, d1f2fA_, 0.9507, 0.78, 0.951, 104, 103, SRC SH2 THREF1TRP MUTANT
39, d1x27F2, 0.9500, 0.95, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
40, d1o4fA_, 0.9487, 0.84, 1.000, 104, 104, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073.
41, d1o4bA_, 0.9485, 0.94, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876.
42, d1o4aA_, 0.9483, 0.95, 1.000, 106, 105, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197.
43, d1spsA_, 0.9463, 0.77, 0.961, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
44, d1sprA_, 0.9458, 0.69, 0.961, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
45, d1o4cA_, 0.9447, 0.89, 1.000, 104, 104, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.
46, d1o4gA_, 0.9438, 0.91, 1.000, 105, 104, CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59.
47, d1sprB_, 0.9417, 1.02, 0.951, 104, 103, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
48, d1shaA_, 0.9412, 0.96, 0.961, 103, 102, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
49, d1nzlB_, 0.9406, 0.89, 0.961, 103, 102, CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYEPYIPI
50, d1shbA_, 0.9396, 0.93, 0.961, 103, 102, CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
51, d1a1aB_, 0.9392, 0.78, 0.990, 102, 102, C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(NN-DIPENTYL AMINE)
52, d1nzvB_, 0.9390, 0.91, 0.961, 103, 102, CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYIPYVPA
53, d1x27B2, 0.9388, 1.04, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
54, d1shdA_, 0.9377, 0.62, 1.000, 101, 101, PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS
55, d1spsB_, 0.9375, 0.90, 0.961, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
56, d1x27D2, 0.9371, 1.09, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
57, d1x27A2, 0.9370, 1.08, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
58, d1lckA2, 0.9368, 1.08, 0.505, 110, 105, SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA
59, d2ptkA2, 0.9361, 0.64, 0.970, 103, 101, CHICKEN SRC TYROSINE KINASE
60, d1x27C2, 0.9361, 1.09, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
61, d1f1wA_, 0.9357, 0.87, 0.951, 104, 103, SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN
62, d1x27E2, 0.9355, 1.10, 0.505, 108, 105, CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS
63, d1fmkA2, 0.9342, 0.67, 1.000, 103, 101, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
64, d1a09B_, 0.9332, 0.93, 1.000, 102, 102, C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU- (NN-DIPENTYL AMINE)
65, d2h8hA2, 0.9329, 0.69, 1.000, 103, 101, SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
66, d1is0B_, 0.9328, 0.69, 0.970, 102, 101, CRYSTAL STRUCTURE OF A COMPLEX OF THE SRC SH2 DOMAIN WITH CONFORMATIONALLY CONSTRAINED PEPTIDE INHIBITOR
67, d1kswA2, 0.9323, 0.69, 1.000, 103, 101, STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
68, d1is0A_, 0.9323, 0.71, 0.970, 102, 101, CRYSTAL STRUCTURE OF A COMPLEX OF THE SRC SH2 DOMAIN WITH CONFORMATIONALLY CONSTRAINED PEPTIDE INHIBITOR
69, p4u1pA_, 0.9318, 1.10, 0.650, 105, 103, HUMAN FYN-SH2 DOMAIN IN COMPLEX WITH A SYNTHETIC HIGH-AFFINITY PHOSPHO-PEPTIDE
70, d1y57A2, 0.9318, 0.72, 1.000, 103, 101, STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
71, d5mtjA_, 0.9315, 0.94, 0.699, 109, 103, YES1-SH2 IN COMPLEX WITH MONOBODY MB(YES_1)
72, d1hcsB_, 0.9306, 1.08, 1.000, 107, 105, NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
73, d1skjA_, 0.9304, 0.77, 0.970, 102, 101, COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX
74, d1sprC_, 0.9302, 0.91, 0.961, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
75, d4k11A2, 0.9288, 0.75, 1.000, 103, 101, THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G
76, d1bkmA_, 0.9283, 1.01, 0.960, 102, 101, COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX
77, d2srcA2, 0.9270, 0.77, 1.000, 103, 101, CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC IN COMPLEX WITH AMP-PNP
78, d1spsC_, 0.9238, 1.12, 0.971, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
79, p6f3fA2, 0.9236, 0.70, 1.000, 100, 100, AUTOINHIBITED SRC KINASE BOUND TO ADP
80, d1bklA1, 0.9235, 0.85, 0.960, 104, 101, SELF-ASSOCIATED APO SRC SH2 DOMAIN
81, d1lkkA_, 0.9224, 1.27, 0.500, 105, 104, HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-ILE (PYEEI PEPTIDE)
82, d5h0gA2, 0.9223, 0.85, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-N4-DIMETHYLPENTANAMIDE
83, d5h0eA2, 0.9215, 0.86, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANAMIDE
84, d5h09A2, 0.9211, 0.86, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-ETHYL2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOATE
85, d5h0bA2, 0.9210, 0.86, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-4-METHYLPENTANOIC ACID
86, d4tziA_, 0.9209, 1.39, 0.486, 110, 105, STRUCTURE OF UNLIGANDED LYN SH2 DOMAIN
87, d5h0hA2, 0.9200, 0.87, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR (S)-2-(((1R4S)-4-(4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-NN4-TRIMETHYLPENTANAMIDE
88, d1sprD_, 0.9194, 1.18, 0.961, 103, 102, BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
89, d1lklA_, 0.9192, 1.15, 0.505, 104, 103, HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-GLY (PYEEG PEPTIDE)
90, d4d8kA2, 0.9179, 1.36, 0.505, 106, 105, CRYSTAL STRUCTURE OF A SH3-SH2 DOMAINS OF A LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE (LCK) FROM HOMO SAPIENS AT 2.36 A RESOLUTION
91, d1bhfA_, 0.9178, 1.32, 0.500, 105, 104, P56LCK SH2 DOMAIN INHIBITOR COMPLEX
92, d1lcjA_, 0.9172, 1.22, 0.505, 104, 103, SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL
93, d1ijrA_, 0.9150, 1.23, 0.515, 104, 103, CRYSTAL STRUCTURE OF LCK SH2 COMPLEXED WITH NONPEPTIDE PHOSPHOTYROSINE MIMETIC
94, d1nzlA_, 0.9142, 0.98, 0.960, 101, 100, CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYEPYIPI
95, d1g83A2, 0.9138, 1.19, 0.670, 104, 103, CRYSTAL STRUCTURE OF FYN SH3-SH2
96, d1nzvA_, 0.9135, 0.96, 0.960, 101, 100, CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYIPYVPA
97, d3vs6A2, 0.9134, 0.97, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
98, d1hctB_, 0.9132, 1.23, 1.000, 107, 105, NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
99, d1qcfA2, 0.9131, 0.93, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELECTIVE TYROSINE KINASE INHIBITOR
100, d3vs1B2, 0.9129, 0.98, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
101, d3vs3A2, 0.9126, 0.99, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
102, d3vryB2, 0.9093, 1.02, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
103, d1fbzB_, 0.9092, 1.27, 0.515, 104, 103, STRUCTURE-BASED DESIGN OF A NOVEL OSTEOCLAST-SELECTIVE NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY
104, d1fbzA_, 0.9092, 1.53, 0.515, 104, 103, STRUCTURE-BASED DESIGN OF A NOVEL OSTEOCLAST-SELECTIVE NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY
105, d4tziB_, 0.9085, 1.38, 0.490, 108, 104, STRUCTURE OF UNLIGANDED LYN SH2 DOMAIN
106, d3vs6B2, 0.9085, 0.99, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[34- D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
107, d3vs4B2, 0.9084, 1.03, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
108, d2jyqA_, 0.9072, 1.23, 0.971, 106, 103, NMR STRUCTURE OF THE APO V-SRC SH2 DOMAIN
109, d3vs0B2, 0.9071, 1.03, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
110, d1g83B2, 0.9050, 1.29, 0.670, 104, 103, CRYSTAL STRUCTURE OF FYN SH3-SH2
111, d2c0oB2, 0.9028, 1.11, 0.545, 103, 101, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
112, d3vs2B2, 0.9027, 1.11, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
113, d2c0iB2, 0.9027, 1.09, 0.545, 103, 101, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
114, d2c0iA2, 0.9007, 1.11, 0.545, 103, 101, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
115, d2c0oA2, 0.8999, 1.13, 0.545, 103, 101, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
116, d3nhnA2, 0.8987, 1.10, 0.545, 101, 101, CRYSTAL STRUCTURE OF THE SRC-FAMILY KINASE HCK SH3-SH2-LINKER REGULATORY REGION
117, p5mtmA_, 0.8980, 1.61, 0.505, 108, 105, MONOBODY MB(LCK_3) BOUND TO LCK-SH2 DOMAIN
118, d2hckB2, 0.8958, 1.13, 0.545, 103, 101, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
119, d3vs7A2, 0.8956, 1.18, 0.545, 103, 101, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
120, d4ludA2, 0.8929, 1.00, 0.545, 101, 99, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
121, d1bhhB_, 0.8899, 1.35, 0.510, 103, 102, FREE P56LCK SH2 DOMAIN
122, d1ad5B2, 0.8894, 1.21, 0.545, 103, 101, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
123, d1ad5A2, 0.8883, 1.20, 0.545, 103, 101, SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
124, d2hckA2, 0.8878, 1.18, 0.545, 103, 101, SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
125, d1kc2A_, 0.8819, 0.77, 0.947, 96, 95, STRUCTURE OF THE TRIPLE (LYS(BETA)D3ALA ASP(BETA)C8ALA ASPCD2ALA) MUTANT OF THE SRC SH2 DOMAIN BOUND TO THE PQPYEEIPI PEPTIDE
126, d4lueB2, 0.8772, 0.96, 0.536, 99, 97, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
127, d1bhhA_, 0.8767, 1.58, 0.505, 104, 103, FREE P56LCK SH2 DOMAIN
128, d3vs2A2, 0.8763, 1.05, 0.541, 100, 98, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[23-D]PYRIMIDIN-4-AMINE
129, d1p13A_, 0.8761, 1.51, 0.960, 102, 101, CRYSTAL STRUCTURE OF THE SRC SH2 DOMAIN COMPLEXED WITH PEPTIDE (SDPYANFK)
130, d4lueA2, 0.8760, 1.01, 0.536, 99, 97, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
131, d3vs5A2, 0.8753, 0.99, 0.536, 99, 97, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
132, d3vrzA2, 0.8751, 1.01, 0.536, 99, 97, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
133, d3vrzB2, 0.8750, 1.01, 0.536, 99, 97, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA
134, d2c0tB2, 0.8744, 1.02, 0.536, 99, 97, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
135, d2dlyA1, 0.8719, 1.22, 0.510, 108, 100, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF MURINE FYN-RELATED KINASE
136, d2mqiA_, 0.8714, 1.15, 0.646, 100, 99, HUMAN FYN SH2 FREE STATE
137, d1p13B_, 0.8696, 1.59, 0.960, 102, 101, CRYSTAL STRUCTURE OF THE SRC SH2 DOMAIN COMPLEXED WITH PEPTIDE (SDPYANFK)
138, p5d0jD_, 0.8679, 1.47, 0.320, 104, 100, GRB7 SH2 WITH INHIBITOR PEPTIDE
139, d3m7fA_, 0.8679, 1.40, 0.270, 107, 100, CRYSTAL STRUCTURE OF THE NEDD4 C2/GRB10 SH2 COMPLEX
140, d3k2mA_, 0.8676, 1.13, 0.378, 100, 98, CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX
141, p5tyiB_, 0.8673, 1.42, 0.320, 105, 100, GRB7 SH2 WITH BICYCLIC PEPTIDE CONTAINING PY MIMETIC
142, d4u5wD2, 0.8673, 0.96, 0.521, 96, 96, CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WITH THE SRC FAMILY KINASE HCK SH3-SH2 TANDEM REGULATORY DOMAINS
143, d3vs0A2, 0.8661, 0.99, 0.542, 98, 96, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
144, p5d0jA_, 0.8657, 1.42, 0.323, 106, 99, GRB7 SH2 WITH INHIBITOR PEPTIDE
145, d3vs3B2, 0.8655, 1.00, 0.531, 98, 96, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)- 7H-PYRROLO[23-D]PYRIMIDIN-4-AMINE
146, d3uf4A2, 0.8655, 1.12, 0.691, 97, 97, CRYSTAL STRUCTURE OF A SH3 AND SH2 DOMAINS OF FYN PROTEIN (PROTO- CONCOGENE TYROSINE-PROTEIN KINASE FYN) FROM MUS MUSCULUS AT 1.98 A RESOLUTION
147, p5d0jB_, 0.8639, 1.51, 0.320, 107, 100, GRB7 SH2 WITH INHIBITOR PEPTIDE
148, d3hckA_, 0.8638, 1.69, 0.539, 107, 102, NMR ENSEMBLE OF THE UNCOMPLEXED HUMAN HCK SH2 DOMAIN 20 STRUCTURES
149, d3gqiB1, 0.8628, 1.36, 0.364, 114, 99, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
150, p4x6sB_, 0.8617, 1.48, 0.320, 107, 100, GRB7 SH2 DOMAIN WITH PHOSPHOTYROSINE MIMETIC INHIBITOR PEPTIDE
151, p5tyiA_, 0.8615, 1.49, 0.320, 104, 100, GRB7 SH2 WITH BICYCLIC PEPTIDE CONTAINING PY MIMETIC
152, p4x6sA_, 0.8615, 1.49, 0.320, 106, 100, GRB7 SH2 DOMAIN WITH PHOSPHOTYROSINE MIMETIC INHIBITOR PEPTIDE
153, p5u06D_, 0.8614, 1.47, 0.320, 103, 100, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR CONTAINING A PY MIMETIC
154, p5u06C_, 0.8612, 1.48, 0.320, 108, 100, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR CONTAINING A PY MIMETIC
155, p5tyiC_, 0.8610, 1.42, 0.323, 104, 99, GRB7 SH2 WITH BICYCLIC PEPTIDE CONTAINING PY MIMETIC
156, d3vs7B2, 0.8609, 1.04, 0.531, 98, 96, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[23-B]PYRIDIN-5-YL)-1H- PYRAZOLO[34-D]PYRIMIDIN-4-AMINE
157, p4m4zA2, 0.8591, 1.81, 0.412, 105, 102, SH3 AND SH2 DOMAINS OF HUMAN SRC-LIKE ADAPTOR PROTEIN 2 (SLAP2)
158, p5eeqA_, 0.8583, 1.81, 0.412, 105, 102, GRB7 SH2 WITH THE G7-B1 BICYCLIC PEPTIDE INHIBITOR
159, p5tyiD_, 0.8577, 1.43, 0.323, 103, 99, GRB7 SH2 WITH BICYCLIC PEPTIDE CONTAINING PY MIMETIC
160, p5eeqB_, 0.8573, 1.44, 0.323, 102, 99, GRB7 SH2 WITH THE G7-B1 BICYCLIC PEPTIDE INHIBITOR
161, d3vs5B2, 0.8563, 1.46, 0.323, 104, 99, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
162, d1blkA_, 0.8538, 0.99, 0.537, 97, 95, NMR ENSEMBLE OF BLK SH2 DOMAIN USING CHEMICAL SHIFT REFINEMENT 20 STRUCTURES
163, p5eelB_, 0.8537, 1.61, 0.525, 114, 101, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
164, p5eelA_, 0.8536, 1.51, 0.320, 109, 100, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
165, d3vryA2, 0.8534, 1.43, 0.323, 104, 99, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[23-D]PYRIMIDIN-7-YL- CYCLOPENTANE
166, d2c0tA2, 0.8534, 1.06, 0.537, 97, 95, SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
167, d3k2mB_, 0.8523, 1.05, 0.537, 97, 95, CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX
168, d1m61A2, 0.8518, 1.17, 0.375, 97, 96, CRYSTAL STRUCTURE OF THE APO SH2 DOMAINS OF ZAP-70
169, d3vs4A2, 0.8511, 1.45, 0.364, 124, 99, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[23- D]PYRIMIDIN-4-AMINE
170, p5eelC_, 0.8507, 1.05, 0.537, 97, 95, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
171, p5u06A_, 0.8506, 1.40, 0.327, 106, 98, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR CONTAINING A PY MIMETIC
172, d1nrvB_, 0.8504, 1.50, 0.323, 107, 99, CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10
173, d2augB1, 0.8490, 1.40, 0.276, 100, 98, CRYSTAL STRUCTURE OF THE GRB14 SH2 DOMAIN
174, p4k2rA3, 0.8476, 1.58, 0.290, 105, 100, STRUCTURAL BASIS FOR ACTIVATION OF ZAP-70 BY PHOSPHORYLATION OF THE SH2-KINASE LINKER
175, d2fo0A2, 0.8476, 1.52, 0.364, 104, 99, ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
176, p4fl3A3, 0.8458, 1.53, 0.378, 101, 98, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
177, p4fbnA1, 0.8456, 1.78, 0.374, 103, 99, INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULATORY REGION AND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KEY ROLES OF SH2 DOMAINS
178, p5u06B_, 0.8452, 1.37, 0.371, 112, 97, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR CONTAINING A PY MIMETIC
179, p2ozoA3, 0.8452, 1.48, 0.327, 102, 98, AUTOINHIBITED INTACT HUMAN ZAP-70
180, d5mo4A2, 0.8451, 1.43, 0.357, 103, 98, ABL1 KINASE (T334I_D382N) IN COMPLEX WITH ASCIMINIB AND NILOTINIB
181, p3pqzB_, 0.8451, 1.53, 0.378, 101, 98, GRB7 SH2 WITH PEPTIDE
182, p4xz1A1, 0.8450, 1.55, 0.323, 105, 99, ZAP-70-TSH2:COMPOUND-B ADDUCT
183, p4fl2A3, 0.8449, 1.60, 0.263, 112, 99, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
184, p5u1qB_, 0.8447, 1.77, 0.374, 105, 99, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR
185, d4wwqA_, 0.8443, 1.59, 0.320, 107, 100, APO STRUCTURE OF THE GRB7 SH2 DOMAIN
186, d1opkA2, 0.8442, 1.88, 0.323, 112, 99, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
187, d1cwdL_, 0.8440, 1.57, 0.378, 101, 98, HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE
188, d3t04A_, 0.8436, 1.62, 0.510, 98, 98, CRYSTAL STRUCTURE OF MONOBODY 7C12/ABL1 SH2 DOMAIN COMPLEX
189, d1oplB1, 0.8434, 1.30, 0.371, 98, 97, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
190, d1oplA2, 0.8434, 1.58, 0.378, 98, 98, STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
191, d1k9aA2, 0.8422, 1.58, 0.378, 101, 98, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
192, p2ozoA1, 0.8419, 1.46, 0.417, 101, 96, AUTOINHIBITED INTACT HUMAN ZAP-70
193, p5eelF_, 0.8418, 1.60, 0.263, 116, 99, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
194, d2augA_, 0.8415, 1.49, 0.327, 104, 98, CRYSTAL STRUCTURE OF THE GRB14 SH2 DOMAIN
195, p3pqzA_, 0.8413, 1.64, 0.290, 105, 100, GRB7 SH2 WITH PEPTIDE
196, p5u1qC_, 0.8411, 1.58, 0.323, 104, 99, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR
197, d2oq1A1, 0.8411, 1.66, 0.320, 105, 100, TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE
198, d1cweC_, 0.8410, 1.49, 0.255, 128, 98, HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE
199, d1a81A1, 0.8410, 1.64, 0.510, 98, 98, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
200, p4fl3A1, 0.8409, 1.72, 0.300, 129, 100, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
201, d1a81G1, 0.8407, 1.65, 0.293, 109, 99, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
202, d1a81K1, 0.8405, 1.70, 0.300, 109, 100, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
203, d1a81C1, 0.8405, 1.70, 0.300, 109, 100, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
204, d1m61A1, 0.8404, 1.72, 0.300, 129, 100, CRYSTAL STRUCTURE OF THE APO SH2 DOMAINS OF ZAP-70
205, p4k2rA1, 0.8402, 1.63, 0.263, 132, 99, STRUCTURAL BASIS FOR ACTIVATION OF ZAP-70 BY PHOSPHORYLATION OF THE SH2-KINASE LINKER
206, d1cweA_, 0.8401, 1.63, 0.263, 132, 99, HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE
207, d1a81I1, 0.8401, 1.62, 0.263, 115, 99, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
208, d1jwoA_, 0.8398, 1.67, 0.510, 98, 98, CRYSTAL STRUCTURE ANALYSIS OF THE SH2 DOMAIN OF THE CSK HOMOLOGOUS KINASE CHK
209, d4xz0A1, 0.8393, 1.72, 0.300, 129, 100, ZAP-70-TSH2:COMPOUND-A COMPLEX
210, d1k9aB2, 0.8390, 1.15, 0.316, 97, 95, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
211, d1k9aE2, 0.8388, 1.63, 0.263, 132, 99, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
212, p5eelD_, 0.8387, 1.34, 0.421, 101, 95, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
213, d1a81E1, 0.8386, 1.52, 0.417, 101, 96, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
214, p4fl2A1, 0.8384, 1.44, 0.330, 102, 97, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
215, p5d0jC_, 0.8380, 1.72, 0.300, 109, 100, GRB7 SH2 WITH INHIBITOR PEPTIDE
216, d4xz0A2, 0.8380, 1.67, 0.293, 109, 99, ZAP-70-TSH2:COMPOUND-A COMPLEX
217, d1bljA_, 0.8378, 1.38, 0.333, 102, 96, NMR ENSEMBLE OF BLK SH2 DOMAIN 20 STRUCTURES
218, d5w3rA1, 0.8374, 1.48, 0.367, 125, 98, SH2B1 SH2 DOMAIN
219, d1nrvA_, 0.8369, 2.04, 0.510, 114, 102, CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10
220, p5u1qD_, 0.8366, 2.04, 0.510, 114, 102, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR
221, p5u1qA_, 0.8365, 1.70, 0.253, 110, 99, GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR
222, p4ey0A1, 0.8353, 1.70, 0.253, 110, 99, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
223, p4ey0C1, 0.8351, 1.51, 0.276, 100, 98, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
224, p4ey0B1, 0.8351, 1.42, 0.333, 101, 96, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
225, d2qmsA_, 0.8350, 1.40, 0.333, 100, 96, CRYSTAL STRUCTURE OF A SIGNALING MOLECULE
226, d2qmsB_, 0.8349, 1.56, 0.371, 113, 97, CRYSTAL STRUCTURE OF A SIGNALING MOLECULE
227, d2qmsC_, 0.8348, 1.56, 0.371, 113, 97, CRYSTAL STRUCTURE OF A SIGNALING MOLECULE
228, p4ey0D1, 0.8347, 1.56, 0.371, 113, 97, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
229, d2qmsD_, 0.8338, 1.57, 0.330, 113, 97, CRYSTAL STRUCTURE OF A SIGNALING MOLECULE
230, p4xz1A3, 0.8333, 1.58, 0.330, 113, 97, ZAP-70-TSH2:COMPOUND-B ADDUCT
231, d1d4tA_, 0.8330, 1.58, 0.330, 113, 97, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE
232, d4jegA1, 0.8329, 1.57, 0.371, 113, 97, CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX
233, d4eihA_, 0.8328, 1.59, 0.330, 113, 97, CRYSTAL STRUCTURE OF ARG SH2 DOMAIN
234, d1d4wA_, 0.8328, 1.61, 0.364, 102, 99, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE
235, d3ps5A2, 0.8317, 1.53, 0.286, 104, 98, CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PROTEIN TYROSINE PHOSPHATASE SHP-1
236, d2oq1A2, 0.8316, 1.99, 0.314, 112, 102, TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE
237, d3uyoA_, 0.8315, 1.99, 0.314, 112, 102, CRYSTAL STRUCTURE OF MONOBODY SH13/ABL1 SH2 DOMAIN COMPLEX
238, d1a81K2, 0.8307, 1.83, 0.367, 101, 98, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
239, d1a81E2, 0.8304, 1.53, 0.286, 104, 98, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
240, d5dc4A_, 0.8290, 1.69, 0.296, 107, 98, CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX CRYSTAL A
241, d1m27A_, 0.8290, 1.71, 0.364, 123, 99, CRYSTAL STRUCTURE OF SAP/FYNSH3/SLAM TERNARY COMPLEX
242, d2hdvA1, 0.8287, 1.74, 0.378, 114, 98, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF THE ADAPTER PROTEIN SH2-B
243, d1a81A2, 0.8286, 1.74, 0.378, 114, 98, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
244, d1d4wB_, 0.8279, 1.57, 0.378, 111, 98, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE
245, d1d1zD_, 0.8278, 1.56, 0.378, 111, 98, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP
246, p5eelE_, 0.8269, 1.66, 0.378, 100, 98, GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR
247, d5kazA_, 0.8264, 1.65, 0.276, 104, 98, HUMAN SH2D1B STRUCTURE
248, d1a81C2, 0.8259, 1.77, 0.235, 102, 98, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
249, d5dc9A_, 0.8258, 1.58, 0.378, 125, 98, CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX CRYSTAL B
250, d2dm0A1, 0.8256, 1.58, 0.378, 125, 98, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN TYROSINE- PROTEIN KINASE TXK
251, d5dc0B_, 0.8248, 1.43, 0.281, 102, 96, CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX
252, d1a81I2, 0.8244, 1.36, 0.274, 101, 95, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
253, d1d1zC_, 0.8243, 1.45, 0.333, 102, 96, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP
254, d2rsyA1, 0.8238, 1.53, 0.320, 103, 97, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF CSK IN COMPLEX WITH A PHOSPHOPEPTIDE FROM CBP
255, d1i3zA_, 0.8238, 1.60, 0.378, 125, 98, MURINE EAT2 SH2 DOMAIN IN COMPLEX WITH SLAM PHOSPHOPEPTIDE
256, d1k9aF2, 0.8234, 1.73, 0.378, 100, 98, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
257, d1d1zA_, 0.8229, 1.90, 0.353, 112, 102, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP
258, d3vs1A2, 0.8202, 1.76, 0.371, 98, 97, CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[23-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA
259, d2hdxF_, 0.8195, 1.77, 0.378, 125, 98, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
260, d2hdxD_, 0.8195, 1.43, 0.274, 101, 95, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
261, d2b3oA2, 0.8192, 1.17, 0.430, 94, 93, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1
262, p4rojB_, 0.8190, 1.53, 0.402, 103, 97, CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE
263, d1a81G2, 0.8190, 1.53, 0.402, 103, 97, CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM
264, d2hdxA_, 0.8178, 1.60, 0.417, 101, 96, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
265, d2hdvB_, 0.8177, 1.42, 0.274, 101, 95, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF THE ADAPTER PROTEIN SH2-B
266, d2hdxE_, 0.8173, 1.11, 0.522, 94, 92, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
267, d1k9aC2, 0.8170, 1.91, 0.242, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
268, p5df6A2, 0.8163, 1.90, 0.242, 105, 99, CRYSTAL STRUCTURE OF PTPN11 TANDEM SH2 DOMAINS IN COMPLEX WITH A TXNIP PEPTIDE
269, d2hdxC_, 0.8161, 1.55, 0.309, 103, 97, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
270, d3us4A_, 0.8150, 1.68, 0.278, 103, 97, CRYSTAL STRUCTURE OF A SH2 DOMAIN OF A MEGAKARYOCYTE-ASSOCIATED TYROSINE KINASE (MATK) FROM HOMO SAPIENS AT 1.50 A RESOLUTION
271, d2hdxB_, 0.8149, 1.69, 0.378, 111, 98, CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE
272, d4xeyB1, 0.8148, 1.88, 0.242, 108, 99, CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL TYROSINE KINASE
273, d3n84E1, 0.8143, 1.90, 0.242, 103, 99, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
274, d4ohdA2, 0.8138, 1.86, 0.242, 108, 99, LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT
275, d1rjaA_, 0.8137, 1.70, 0.421, 101, 95, SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE NONRECEPTOR TYROSINE KINASE PTK6/BRK SH2 DOMAIN
276, d1ka6A_, 0.8134, 2.32, 0.307, 110, 101, SAP/SH2D1A BOUND TO PEPTIDE N-PY
277, d2ablA2, 0.8132, 1.92, 0.242, 108, 99, SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE
278, d3pqzD_, 0.8130, 1.26, 0.333, 94, 93, GRB7 SH2 WITH PEPTIDE
279, d3n84F_, 0.8130, 1.91, 0.242, 105, 99, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
280, d2crhA1, 0.8128, 1.36, 0.372, 95, 94, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTO- ONCOGENE PROTEIN VAV1
281, d3n84A_, 0.8123, 1.86, 0.323, 101, 96, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
282, d4dgpA2, 0.8120, 1.70, 0.302, 101, 96, THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)
283, d3n84C_, 0.8119, 1.67, 0.375, 100, 96, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
284, d4dgxA2, 0.8117, 1.67, 0.375, 100, 96, LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT
285, p1x6cA_, 0.8115, 1.79, 0.265, 107, 98, SOLUTION STRUCTURES OF THE SH2 DOMAIN OF HUMAN PROTEIN- TYROSINE PHOSPHATASE SHP-1
286, p5x7bA2, 0.8110, 1.79, 0.265, 107, 98, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_C PEPTIDE COMPLEX
287, d1bm2A_, 0.8108, 1.82, 0.375, 98, 96, GRB2-SH2 DOMAIN IN COMPLEX WITH CYCLO-[N-ALPHA-ACETYL-L-THI ALYSYL-O-PHOSPHOTYROSYL-VALYL-ASPARAGYL-VALYL-PROLYL] (PKF273-791)
288, d3n84B_, 0.8106, 1.53, 0.337, 97, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
289, d4ohhA2, 0.8101, 1.87, 0.323, 101, 96, LEOPARD SYNDROME-ASSOCIATED SHP2/Q506P MUTANT
290, d3n84D_, 0.8101, 1.76, 0.302, 125, 96, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
291, d2ysxA1, 0.8101, 1.76, 0.302, 125, 96, SOLUTION STRUCTURE OF THE HUMAN SHIP SH2 DOMAIN
292, d2huwA_, 0.8098, 1.64, 0.326, 109, 95, X-RAY CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN COMPLEXED TO A CONSTRAINED AND CYCLOPROPANE-DERIVED LIGAND
293, d3in7C_, 0.8097, 1.79, 0.309, 108, 97, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A CYCLOPROPYL-CONSTRAINED AC-PY-Q-N-NH2 TRIPEPTIDE MIMIC
294, d3n7yC_, 0.8095, 1.64, 0.326, 109, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV
295, p4rojA_, 0.8086, 1.80, 0.309, 108, 97, CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE
296, p2ci9B_, 0.8082, 2.05, 0.300, 118, 100, NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR
297, d3imjA_, 0.8078, 2.05, 0.300, 118, 100, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A CYCLOPROPYL-CONSTRAINED AC-PTYR-ILE-ASN-NH2 TRIPEPTIDE MIMIC
298, p3pqzC_, 0.8077, 1.71, 0.312, 103, 96, GRB7 SH2 WITH PEPTIDE
299, d3imdB_, 0.8077, 1.52, 0.330, 98, 94, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A FLEXIBLE AC-PY-Q-N-NH2 TRIPEPTIDE MIMIC
300, d5xzrA2, 0.8075, 1.65, 0.326, 106, 95, THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT IN COMPLEX WITH ALLOSTERIC INHIBITOR 9B
301, p4rojC_, 0.8074, 1.85, 0.309, 104, 97, CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE
302, d3n7yA_, 0.8074, 1.66, 0.326, 101, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV
303, d3imdA_, 0.8074, 1.68, 0.340, 112, 97, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A FLEXIBLE AC-PY-Q-N-NH2 TRIPEPTIDE MIMIC
304, d5ibsA2, 0.8071, 1.68, 0.340, 112, 97, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
305, p5tqsA_, 0.8068, 1.65, 0.326, 101, 95, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE RECEPTOR TYROSINE KINASE ERBB2
306, d5i6vA2, 0.8068, 1.66, 0.326, 100, 95, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
307, d3eazA_, 0.8068, 1.96, 0.323, 98, 96, CRYSTAL STRUCTURE OF SH2 DOMAIN OF HUMAN CSK (CARBOXYL-TERMINAL SRC KINASE) C122S MUTANT.
308, p2rorA_, 0.8067, 1.73, 0.289, 103, 97, SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM SLP76
309, d3n7yB_, 0.8063, 1.79, 0.263, 100, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV
310, d3eacA_, 0.8059, 1.66, 0.326, 101, 95, CRYSTAL STRUCTURE OF SH2 DOMAIN OF HUMAN CSK (CARBOXYL-TERMINAL SRC KINASE) OXIDIZED FORM.
311, d3kfjA_, 0.8058, 1.50, 0.340, 97, 94, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A FLEXIBLE AC-PY-E-N-NH2 TRIPEPTIDE MIMIC
312, p5x94A2, 0.8056, 1.67, 0.326, 101, 95, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_D PEPTIDE COMPLEX
313, d4nwfB2, 0.8053, 2.11, 0.306, 108, 98, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
314, d3ov1A_, 0.8049, 1.74, 0.289, 103, 97, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE
315, d3in7A_, 0.8049, 1.56, 0.330, 98, 94, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A CYCLOPROPYL-CONSTRAINED AC-PY-Q-N-NH2 TRIPEPTIDE MIMIC
316, d3s8oA_, 0.8048, 1.67, 0.326, 101, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE
317, d3s8nA_, 0.8045, 1.68, 0.316, 100, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE
318, d3imjB_, 0.8044, 1.53, 0.263, 101, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A CYCLOPROPYL-CONSTRAINED AC-PTYR-ILE-ASN-NH2 TRIPEPTIDE MIMIC
319, d3s8lA_, 0.8043, 1.63, 0.316, 100, 95, PROTEIN-LIGAND INTERACTIONS: THERMODYNAMIC EFFECTS ASSOCIATED WITH INCREASING HYDROPHOBIC SURFACE AREA
320, p5tq1A_, 0.8042, 1.66, 0.406, 102, 96, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE INSULIN RECEPTOR
321, p4p9vA_, 0.8042, 1.66, 0.406, 102, 96, GRB2 SH2 COMPLEXED WITH A PTYR-AC6CN-ASN TRIPEPTIDE
322, d4je4A1, 0.8042, 1.52, 0.292, 105, 96, CRYSTAL STRUCTURE OF MONOBODY NSA1/SHP2 N-SH2 DOMAIN COMPLEX
323, d3in8A_, 0.8042, 1.56, 0.330, 98, 94, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A FLEXIBLE AC-PTYR-ILE-ASN-NH2 TRIPEPTIDE MIMIC
324, d1cj1L_, 0.8041, 1.67, 0.406, 101, 96, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
325, d1cj1K_, 0.8041, 1.69, 0.326, 100, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
326, d1cj1J_, 0.8041, 1.73, 0.312, 102, 96, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
327, d1cj1I_, 0.8041, 1.72, 0.312, 102, 96, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
328, d1cj1H_, 0.8041, 1.69, 0.326, 101, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
329, d1cj1G_, 0.8041, 1.69, 0.326, 99, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
330, d1cj1F_, 0.8041, 1.69, 0.326, 101, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
331, d1cj1E_, 0.8041, 1.69, 0.326, 101, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
332, d1cj1D_, 0.8041, 1.71, 0.326, 100, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
333, d1cj1C_, 0.8041, 1.70, 0.326, 101, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
334, d1cj1B_, 0.8041, 1.57, 0.263, 101, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
335, d1cj1A_, 0.8041, 1.70, 0.326, 100, 95, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE
336, d4wwqB1, 0.8037, 1.70, 0.305, 101, 95, APO STRUCTURE OF THE GRB7 SH2 DOMAIN
337, d3oveA_, 0.8036, 1.69, 0.326, 101, 95, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE
338, d5i6vB2, 0.8035, 1.56, 0.330, 96, 94, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
339, d4ohiA2, 0.8033, 1.56, 0.330, 96, 94, LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT
340, p5gjiA_, 0.8026, 1.56, 0.330, 96, 94, PI3K P85 N-TERMINAL SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX
341, p3wa4A_, 0.8020, 1.56, 0.330, 96, 94, GRB2 SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX
342, d1zfpE_, 0.8020, 1.56, 0.330, 96, 94, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PENTAPEPTIDE
343, p4p9zA_, 0.8019, 1.56, 0.330, 96, 94, GRB2 SH2 COMPLEXED WITH A PTYR-AC6C-ASN TRIPEPTIDE
344, d3c7iA_, 0.8019, 1.56, 0.330, 96, 94, X-RAY CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE GRB2-SH2 DOMAIN AND A FLEXIBLE LIGAND FPTVN.
345, d2rvfA1, 0.8019, 1.56, 0.330, 96, 94, SOLUTION NMR STRUCTURE OF MONOSIGA BREVICOLLIS CRK/CRKL HOMOLOG (CRKA1) SH2 DOMAIN
346, d2huyA_, 0.8019, 1.56, 0.330, 96, 94,  
347, d1h9oA_, 0.8018, 1.56, 0.330, 96, 94, PHOSPHATIDYLINOSITOL 3-KINASE P85-ALPHA SUBUNIT: C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR CRYSTAL STRUCTURE AT 1.79 A
348, d1aycA_, 0.8018, 1.56, 0.330, 96, 94, CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
349, d4h1oA2, 0.8009, 1.56, 0.330, 96, 94, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION
350, d2shpA3, 0.8009, 2.10, 0.316, 118, 98, TYROSINE PHOSPHATASE SHP-2
351, p5x7bA1, 0.8007, 1.70, 0.326, 101, 95, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_C PEPTIDE COMPLEX
352, d4oheA2, 0.8007, 1.50, 0.309, 99, 94, LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT
353, d2shpB3, 0.8007, 2.09, 0.316, 108, 98, TYROSINE PHOSPHATASE SHP-2
354, d2huwB_, 0.8006, 1.75, 0.299, 107, 97, X-RAY CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN COMPLEXED TO A CONSTRAINED AND CYCLOPROPANE-DERIVED LIGAND
355, d2ekxA1, 0.8006, 1.64, 0.340, 96, 94, SOLUTION STRUCTURE OF THE HUMAN BMX SH2 DOMAIN
356, d1aydA_, 0.8006, 1.73, 0.326, 98, 95, CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
357, d4gwfA2, 0.8002, 1.60, 0.330, 99, 94, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
358, d4k44B1, 0.8001, 1.71, 0.326, 101, 95, AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES
359, d3mxcA_, 0.7997, 1.64, 0.340, 96, 94, STRUCTURES OF GRB2-SH2 DOMAIN AND AICD PEPTIDE COMPLEXES REVEAL A CONFORMATIONAL SWITCH AND THEIR FUNCTIONAL IMPLICATIONS.
360, p5xgjB1, 0.7995, 1.64, 0.340, 96, 94, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
361, d1r1qA_, 0.7991, 1.71, 0.326, 101, 95, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
362, p5xghB1, 0.7990, 1.55, 0.323, 108, 93, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
363, d2cs0A1, 0.7989, 1.55, 0.309, 100, 94, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN HSH2D PROTEIN
364, p5x94B2, 0.7983, 1.68, 0.305, 102, 95, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_D PEPTIDE COMPLEX
365, p4l2yB1, 0.7983, 1.91, 0.312, 103, 96, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D
366, p2mrkA_, 0.7978, 1.65, 0.305, 103, 95, FYN SH2 DOMAIN IN COMPLEX WITH THE NATURAL INHIBITORY PHOSPHOTYROSINE PEPTIDE
367, p5tqsB_, 0.7976, 1.49, 0.312, 98, 93, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE RECEPTOR TYROSINE KINASE ERBB2
368, p4l23B1, 0.7975, 1.91, 0.312, 103, 96, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103
369, d3mxyA1, 0.7975, 1.78, 0.326, 98, 95, STRUCTURES OF GRB2-SH2 DOMAIN AND AICD PEPTIDE COMPLEXES REVEAL A CONFORMATIONAL SWITCH AND THEIR FUNCTIONAL IMPLICATIONS.
370, p4l1bB1, 0.7972, 1.97, 0.297, 103, 101, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA
371, d4ohlB2, 0.7971, 1.73, 0.305, 101, 95, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
372, p2vifA_, 0.7970, 1.55, 0.309, 99, 94, CRYSTAL STRUCTURE OF SOCS6 SH2 DOMAIN IN COMPLEX WITH A C-KIT PHOSPHOPEPTIDE
373, p3tkzA_, 0.7969, 1.44, 0.269, 102, 93, STRUCTURE OF THE SHP-2 N-SH2 DOMAIN IN A 1:2 COMPLEX WITH RVIPYFVPLNR PEPTIDE
374, d1aybA_, 0.7969, 1.68, 0.330, 98, 94, CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
375, d1r1sC_, 0.7967, 1.92, 0.299, 110, 97, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
376, d5ibmB2, 0.7966, 1.76, 0.277, 97, 94, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
377, p2rmxA_, 0.7966, 1.93, 0.299, 110, 97, SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A
378, d2k79B1, 0.7966, 1.62, 0.316, 106, 95, SOLUTION STRUCTURE OF THE BINARY COMPLEX BETWEEN THE SH3 AND SH2 DOMAIN OF INTERLEUKIN-2 TYROSINE KINASE
379, d5tnwB1, 0.7965, 1.62, 0.316, 106, 95, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN
380, p5df6A1, 0.7965, 1.74, 0.316, 102, 95, CRYSTAL STRUCTURE OF PTPN11 TANDEM SH2 DOMAINS IN COMPLEX WITH A TXNIP PEPTIDE
381, d3n8mA_, 0.7964, 1.95, 0.299, 110, 97, CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH AN ACYCLIC LIGAND HAVING THE SEQUENCE PYVNVP
382, p3hhmB1, 0.7963, 1.89, 0.596, 100, 99, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN
383, d2ciaA1, 0.7960, 1.61, 0.263, 100, 95, HUMAN NCK2 SH2-DOMAIN IN COMPLEX WITH A DECAPHOSPHOPEPTIDE FROM TRANSLOCATED INTIMIN RECEPTOR (TIR) OF EPEC
384, d1r1sA_, 0.7960, 1.95, 0.299, 110, 97, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
385, d4ohlA2, 0.7959, 1.65, 0.330, 98, 94, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
386, d2eo6A1, 0.7958, 1.95, 0.299, 111, 97, SOLUTION STRUCTURE OF THE SH2 DOMAIN FROM MOUSE B-CELL LINKER PROTEIN BLNK
387, d1tzeE_, 0.7958, 1.51, 0.312, 98, 93, SIGNAL TRANSDUCTION ADAPTOR GROWTH FACTOR GRB2 SH2 DOMAIN COMPLEXED WITH PHOSPHOTYROSYL HEPTAPEPTIDE LYS-PRO-PHE-PTYR-VAL-ASN-VAL-NH2 (KFPPYVNC-NH2)
388, d5i6vB1, 0.7957, 1.79, 0.289, 131, 97, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
389, d2gsbA1, 0.7957, 1.79, 0.289, 131, 97, SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN OF HUMAN RAS GTPASE-ACTIVATING PROTEIN 1
390, p5xgiB1, 0.7955, 1.57, 0.309, 100, 94, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
391, p4gl9G_, 0.7951, 1.56, 0.309, 100, 94, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
392, d1bmbA_, 0.7943, 1.72, 0.277, 96, 94, GRB2-SH2 DOMAIN IN COMPLEX WITH KPFY*VNVEF (PKF270-974)
393, d2k7aB1, 0.7942, 1.51, 0.312, 98, 93, ENSEMBLE STRUCTURES OF THE BINARY COMPLEX BETWEEN THE SH3 AND SH2 DOMAIN OF INTERLEUKIN-2 TYROSINE KINASE.
394, p2yu7A_, 0.7938, 2.08, 0.290, 118, 100, SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A
395, p4ey0C2, 0.7937, 2.08, 0.304, 107, 102, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
396, p4ey0B2, 0.7937, 1.54, 0.266, 96, 94, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
397, d5tnwA1, 0.7934, 1.61, 0.309, 102, 94, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN
398, p4ey0D2, 0.7934, 1.77, 0.326, 99, 95, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
399, p6atdA1, 0.7933, 1.75, 0.312, 104, 96, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
400, d4nwfB1, 0.7931, 1.56, 0.293, 97, 92, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
401, p4ey0A2, 0.7931, 1.59, 0.269, 96, 93, STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1
402, p4ovuB1, 0.7928, 1.53, 0.312, 98, 93, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
403, p5x94B1, 0.7926, 2.13, 0.222, 128, 99, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_D PEPTIDE COMPLEX
404, d1ayaB_, 0.7926, 2.13, 0.222, 128, 99, CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
405, d4ohlB1, 0.7923, 1.66, 0.330, 98, 94, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
406, d5eg3B_, 0.7922, 1.85, 0.305, 109, 95, CRYSTAL STRUCTURE OF THE ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH THE CSH2 DOMAIN OF PHOSPHOLIPASE C GAMMA (PLCGAMMA)
407, d3ps5A1, 0.7922, 2.06, 0.265, 106, 98, CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PROTEIN TYROSINE PHOSPHATASE SHP-1
408, d4oheA1, 0.7919, 2.06, 0.265, 106, 98, LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT
409, d4nwfA2, 0.7918, 1.95, 0.299, 110, 97, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
410, d4h1oA1, 0.7918, 1.71, 0.271, 125, 96, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION
411, p5x94A1, 0.7916, 1.79, 0.326, 98, 95, CRYSTAL STRUCTURE OF SHP2_SH2-CAGA EPIYA_D PEPTIDE COMPLEX
412, p2eo3A_, 0.7914, 2.02, 0.297, 107, 101, SOLUTION STRUCTURE OF THE SH2 DOMAIN FROM HUMAN CRK-LIKE PROTEIN
413, p4fbnA2, 0.7912, 2.14, 0.310, 118, 100, INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULATORY REGION AND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KEY ROLES OF SH2 DOMAINS
414, d1griA3, 0.7912, 1.62, 0.263, 121, 95, GRB2
415, d4ohlA1, 0.7908, 1.63, 0.263, 121, 95, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
416, p5ul1B1, 0.7905, 1.58, 0.266, 96, 94, THE CO-STRUCTURE OF 3-AMINO-6-(4-((1-(DIMETHYLAMINO)PROPAN-2-YL) SULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
417, d4k44A1, 0.7903, 1.63, 0.263, 121, 95, AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES
418, d1ayaA_, 0.7902, 1.93, 0.305, 123, 95, CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
419, p5aulA_, 0.7901, 1.90, 0.305, 102, 95, PI3K P85 C-TERMINAL SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX
420, d2shpA2, 0.7901, 1.63, 0.263, 121, 95, TYROSINE PHOSPHATASE SHP-2
421, d5ibmA2, 0.7900, 1.63, 0.263, 121, 95, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
422, d3gqiB2, 0.7900, 1.89, 0.309, 104, 97, CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
423, d5to4A1, 0.7898, 1.80, 0.305, 102, 95, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN SPACEGROUP P212121
424, d2shpB2, 0.7898, 1.75, 0.305, 101, 95, TYROSINE PHOSPHATASE SHP-2
425, p5ukjB1, 0.7896, 1.82, 0.305, 108, 95, THE CO-STRUCTURE OF NN-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[23- B]PYRIDIN-4-YL)-4567-TETRAHYDROPYRAZOLO[15- A]PYRAZIN-3- YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
426, p6atdB1, 0.7894, 1.67, 0.263, 113, 95, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
427, p4gl9H_, 0.7893, 1.76, 0.245, 108, 94, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
428, d1griB3, 0.7893, 1.83, 0.295, 108, 95, GRB2
429, p3tl0A_, 0.7888, 1.71, 0.309, 99, 94, STRUCTURE OF SHP2 N-SH2 DOMAIN IN COMPLEX WITH RLNPYAQLWHR PEPTIDE
430, p2mc1A_, 0.7885, 1.89, 0.305, 105, 95, SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A SYK-DERIVED SINGLY PHOSPHORYLATED PEPTIDE
431, p2ci9A_, 0.7881, 1.68, 0.309, 101, 94, NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR
432, d1aotF_, 0.7881, 1.86, 0.347, 111, 95, NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE MINIMIZED AVERAGE STRUCTURE
433, p6bmrA1, 0.7880, 1.67, 0.263, 120, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
434, p6bmxA1, 0.7879, 1.90, 0.326, 100, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
435, p4qsyA_, 0.7878, 1.93, 0.305, 108, 95, SHP2 SH2 DOMAIN IN COMPLEX WITH GAB1 PEPTIDE
436, d4gwfB2, 0.7878, 1.73, 0.316, 101, 95, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
437, d2lnxA_, 0.7878, 1.53, 0.269, 101, 93, SOLUTION STRUCTURE OF VAV2 SH2 DOMAIN
438, p6bmvB1, 0.7873, 1.69, 0.305, 101, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
439, d5ehpA1, 0.7873, 1.53, 0.326, 108, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
440, p6bmrB1, 0.7870, 1.92, 0.305, 109, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
441, p3qwyA1, 0.7866, 1.51, 0.315, 97, 92, CED-2
442, d4h34A2, 0.7865, 1.68, 0.263, 112, 95, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION
443, d4gwfB1, 0.7864, 1.60, 0.266, 96, 94, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
444, d1milA_, 0.7861, 1.92, 0.305, 109, 95, TRANSFORMING PROTEIN
445, p3qwxX1, 0.7858, 1.69, 0.316, 101, 95, CED-2 1-174
446, p6bmwB1, 0.7857, 1.93, 0.305, 123, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
447, d2eobA1, 0.7853, 1.75, 0.271, 125, 96, SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN FROM RAT PLC GAMMA-2
448, d1aouF_, 0.7852, 1.91, 0.326, 100, 95, NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE 22 STRUCTURES
449, d1csyA1, 0.7848, 1.62, 0.312, 99, 93, SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR NMR
450, p6bmvA1, 0.7847, 2.04, 0.299, 107, 97, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
451, d2mrjA_, 0.7847, 2.06, 0.268, 102, 97, STRUCTURE OF FYN PROTEIN SH2 BOUND
452, d1ka7A_, 0.7847, 2.06, 0.268, 102, 97, SAP/SH2D1A BOUND TO PEPTIDE N-Y-C
453, d4ohiA1, 0.7846, 2.35, 0.625, 106, 104, LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT
454, d4nwgB2, 0.7844, 1.99, 0.305, 142, 95, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
455, p6bmxB1, 0.7843, 1.99, 0.305, 142, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
456, d1r1pC1, 0.7843, 2.01, 0.305, 142, 95, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
457, d5xzrA1, 0.7840, 1.57, 0.312, 100, 93, THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT IN COMPLEX WITH ALLOSTERIC INHIBITOR 9B
458, d5ibsB1, 0.7829, 1.50, 0.315, 97, 92, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
459, d4h34A1, 0.7826, 1.71, 0.271, 113, 96, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION
460, d1r1qB1, 0.7820, 1.71, 0.271, 113, 96, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
461, p4k45A_, 0.7819, 1.81, 0.309, 140, 94, AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES
462, p4gl9E_, 0.7819, 2.01, 0.305, 106, 95, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
463, p3qwyB1, 0.7819, 1.81, 0.309, 140, 94, CED-2
464, d5ehpB1, 0.7818, 2.25, 0.265, 109, 98, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
465, p6amvA1, 0.7812, 1.49, 0.315, 97, 92, ABL 1B REGULATORY MODULE  INHIBITING STATE 
466, p4gl9F_, 0.7811, 1.99, 0.316, 102, 95, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS3 IN COMPLEX WITH JAK2 KINASE DOMAIN AND FRAGMENT OF GP130 INTRACELLULAR DOMAIN
467, d2iugA1, 0.7810, 1.65, 0.319, 104, 94, CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN
468, p5gjhA_, 0.7809, 1.65, 0.319, 104, 94, GADS SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX
469, d2iuhA1, 0.7807, 2.28, 0.263, 111, 99, CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH C-KIT PHOSPHOTYROSYL PEPTIDE
470, d1r1pB1, 0.7806, 2.28, 0.263, 111, 99, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
471, p5gjhC_, 0.7802, 1.87, 0.309, 97, 94, GADS SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX
472, d1lukA1, 0.7798, 1.82, 0.302, 111, 96, NMR STRUCTURE OF THE ITK SH2 DOMAIN PRO287CIS ENERGY MINIMIZED AVERAGE STRUCTURE
473, d2iuiB1, 0.7797, 2.42, 0.627, 106, 102, CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH PDGFR PHOSPHOTYROSYL PEPTIDE
474, d2iuiA1, 0.7797, 2.06, 0.381, 103, 97, CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH PDGFR PHOSPHOTYROSYL PEPTIDE
475, d2izvA2, 0.7794, 2.04, 0.305, 140, 95, CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION
476, p6bmuB1, 0.7793, 1.91, 0.657, 100, 99, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
477, d5ehpA2, 0.7792, 1.94, 0.286, 107, 98, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
478, p6bmyB1, 0.7787, 2.02, 0.295, 108, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
479, d4ohhA1, 0.7784, 1.70, 0.301, 98, 93, LEOPARD SYNDROME-ASSOCIATED SHP2/Q506P MUTANT
480, p2y3aB1, 0.7781, 1.88, 0.309, 120, 94, CRYSTAL STRUCTURE OF P110BETA IN COMPLEX WITH ICSH2 OF P85BETA AND THE DRUG GDC-0941
481, p6atdB3, 0.7779, 1.91, 0.269, 98, 93, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
482, p6atdA3, 0.7778, 1.96, 0.305, 110, 95, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
483, d4dgxA1, 0.7775, 1.64, 0.337, 100, 92, LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT
484, d2dlzA1, 0.7775, 1.73, 0.312, 100, 93, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTEIN VAV-2
485, p6amwA2, 0.7769, 1.77, 0.269, 98, 93, ABL1B REGULATORY MODULE  ACTIVATING  CONFORMATION
486, p6bmwA2, 0.7767, 1.61, 0.272, 102, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
487, p2knoA_, 0.7762, 1.74, 0.274, 124, 95, NMR SOLUTION STRUCTURE OF SH2 DOMAIN OF THE HUMAN TENSIN LIKE C1 DOMAIN CONTAINING PHOSPHATASE (TENC1)
488, d4dgpA1, 0.7758, 2.28, 0.265, 109, 98, THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)
489, d2ecdA1, 0.7753, 1.84, 0.301, 100, 93, SOLUTION STRUCTURE OF THE HUMAN ABL2 SH2 DOMAIN
490, d1cszA1, 0.7753, 1.58, 0.385, 91, 91, SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR NMR
491, p4z32A3, 0.7752, 1.75, 0.274, 126, 95, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
492, d4nwgA2, 0.7750, 1.75, 0.274, 126, 95, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
493, p5tqsC_, 0.7746, 1.78, 0.301, 103, 93, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE RECEPTOR TYROSINE KINASE ERBB2
494, p6c7yB_, 0.7743, 1.70, 0.264, 97, 91, CRYSTAL STRUCTURE OF INHIBITORY PROTEIN SOCS1 IN COMPLEX WITH JAK1 KINASE DOMAIN 
495, d1r1pD_, 0.7742, 1.80, 0.301, 109, 93, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
496, d2eu0A1, 0.7741, 1.97, 0.280, 98, 93, THE NMR ENSEMBLE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE
497, p4z32F3, 0.7735, 1.54, 0.267, 96, 90, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
498, d5ehrB2, 0.7732, 2.22, 0.301, 107, 103, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
499, d1luiA1, 0.7730, 1.59, 0.304, 102, 92, NMR STRUCTURES OF ITK SH2 DOMAIN PRO287CIS ISOFORM ENSEMBLE OF 20 LOW ENERGY STRUCTURES
500, p6bmvA2, 0.7726, 1.57, 0.304, 102, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
501, d5jn0A_, 0.7721, 1.78, 0.219, 112, 96, CRK-II SH2 DOMAIN
502, p6bmrA2, 0.7719, 1.78, 0.219, 112, 96, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
503, d4nwgB1, 0.7718, 1.93, 0.309, 96, 94, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
504, d5ibmB1, 0.7716, 1.51, 0.319, 95, 91, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
505, d1jyrA1, 0.7716, 1.95, 0.309, 96, 94, XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED PEPTIDE
506, d2dx0A_, 0.7715, 2.02, 0.305, 108, 95, CRYSTAL STRUCTURE OF THE N-TERMINAL SH2 DOMAIN OF MOUSE PHOSPHOLIPASE C-GAMMA 2
507, d1jyqA1, 0.7714, 1.73, 0.333, 111, 93, XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A HIGHLY AFFINE PHOSPHO PEPTIDE
508, d2mk2A1, 0.7709, 1.67, 0.326, 96, 92, SOLUTION NMR STRUCTURE OF N-TERMINAL DOMAIN (SH2 DOMAIN) OF HUMAN INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE PROTEIN 1 (INPPL1) (FRAGMENT 20-117) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR9134A
509, p6bmuB2, 0.7689, 1.67, 0.326, 97, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
510, p5swgB1, 0.7687, 2.04, 0.305, 108, 95, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 5 AND 21
511, p6bmyB2, 0.7682, 1.59, 0.287, 105, 94, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
512, p2lctA_, 0.7682, 1.76, 0.383, 101, 94, SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A SYK-DERIVED DOUBLY PHOSPHORYLATED PEPTIDE
513, p4z32B3, 0.7679, 1.61, 0.326, 98, 92, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
514, p5tqsD_, 0.7677, 2.36, 0.283, 117, 99, PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE RECEPTOR TYROSINE KINASE ERBB2
515, d4nwgA1, 0.7675, 2.36, 0.283, 117, 99, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
516, p6bmwA1, 0.7669, 2.06, 0.305, 108, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
517, d1jyqB1, 0.7668, 2.17, 0.357, 106, 98, XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A HIGHLY AFFINE PHOSPHO PEPTIDE
518, p6bmuA1, 0.7663, 1.98, 0.389, 103, 95, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
519, d1r1sG1, 0.7659, 2.08, 0.220, 104, 100, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
520, d1r1sE1, 0.7659, 2.08, 0.220, 104, 100, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
521, d1k9aD2, 0.7658, 1.71, 0.293, 97, 92, CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
522, d4ohdA1, 0.7657, 2.14, 0.263, 98, 95, LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT
523, p6bmyA1, 0.7655, 1.77, 0.266, 117, 94, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
524, p3bkbA1, 0.7655, 1.65, 0.250, 95, 92, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)
525, p6bmxA2, 0.7641, 2.24, 0.311, 107, 103, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
526, d1ghuA_, 0.7631, 2.04, 0.222, 100, 99, NMR SOLUTION STRUCTURE OF GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) SH2 DOMAIN 24 STRUCTURES
527, p2dvjA1, 0.7629, 1.56, 0.319, 96, 91, PHOSPHORYLATED CRK-II
528, d1ju5A_, 0.7628, 2.10, 0.287, 107, 101, TERNARY COMPLEX OF AN CRK SH2 DOMAIN CRK-DERIVED PHOPHOPEPTIDE AND ABL SH3 DOMAIN BY NMR SPECTROSCOPY
529, d1r1pA_, 0.7625, 1.50, 0.322, 94, 90, STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS
530, d5i6vA1, 0.7607, 1.79, 0.352, 96, 91, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
531, d1qg1E1, 0.7606, 1.50, 0.322, 94, 90, GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH AN SHC-DERIVED PEPTIDE
532, d2etzA1, 0.7601, 1.97, 0.312, 102, 93, THE NMR MINIMIZED AVERAGE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE
533, d2b3oA1, 0.7599, 1.86, 0.326, 99, 92, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1
534, p6bmuA2, 0.7588, 1.60, 0.344, 92, 90, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
535, p5swoB1, 0.7588, 1.91, 0.341, 117, 91, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 4 AND 19
536, d5ehrA2, 0.7583, 1.91, 0.341, 117, 91, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
537, d1qadA_, 0.7583, 1.57, 0.344, 92, 90, CRYSTAL STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85 ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE: AN SH2 DOMAIN MIMICKING ITS OWN SUBSTRATE
538, p3hizB1, 0.7579, 1.71, 0.290, 98, 93, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA
539, p6c5xA1, 0.7578, 1.61, 0.308, 97, 91, CRYSTAL STRUCTURE OF SOCS1 IN COMPLEX WITH ELONGINB AND ELONGINC 
540, p6bmyA2, 0.7577, 1.86, 0.312, 98, 93, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
541, d1d1zB_, 0.7577, 1.61, 0.308, 97, 91, CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP
542, p4e93A1, 0.7576, 1.90, 0.302, 107, 96, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)IN COMPLEX WITH TAE684
543, p6bmrB2, 0.7574, 2.14, 0.220, 104, 100, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
544, d2kk6A1, 0.7569, 1.91, 0.269, 99, 93, SOLUTION STRUCTURE OF SH2 DOMAIN OF PROTO-ONCOGENE TYROSINE- PROTEIN KINASE FER FROM HOMO SAPIENS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR3461D
545, p6bmvB2, 0.7568, 1.96, 0.312, 107, 93, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
546, p6c5xD1, 0.7567, 2.01, 0.312, 96, 93, CRYSTAL STRUCTURE OF SOCS1 IN COMPLEX WITH ELONGINB AND ELONGINC 
547, d4gwfA1, 0.7566, 1.62, 0.344, 92, 90, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
548, d1lunA1, 0.7557, 2.04, 0.312, 97, 93, NMR STRUCTURE OF THE ITK SH2 DOMAIN PRO287TRANS ENERGY MINIMIZED AVERAGE STRUCTURE
549, p5fi4B1, 0.7547, 1.72, 0.250, 98, 92, DISCOVERY OF IMIDAZO[12-A]-PYRIDINE INHIBITORS OF PAN-PI3 KINASES THAT ARE EFFICACIOUS IN A MOUSE XENOGRAFT MODEL
550, d5ehrA1, 0.7547, 1.71, 0.250, 98, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
551, d1lumA1, 0.7544, 1.65, 0.432, 94, 88, NMR STRUCTURE OF THE ITK SH2 DOMAIN PRO287TRANS 20 LOW ENERGY STRUCTURES
552, p5l04A2, 0.7534, 2.12, 0.295, 109, 95, STRUCTURE OF INTERFERON LAMBDA 1 RECEPTOR WITH HUMAN KINASE JAK1
553, d5ibsB2, 0.7534, 2.02, 0.312, 97, 93, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
554, p2lnwA_, 0.7532, 1.67, 0.290, 103, 93, IDENTIFICATION AND STRUCTURAL BASIS FOR A NOVEL INTERACTION BETWEEN VAV2 AND ARAP3
555, d4nwfA1, 0.7524, 1.51, 0.326, 93, 89, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
556, p2hmhA_, 0.7522, 2.11, 0.333, 95, 93, CRYSTAL STRUCTURE OF SOCS3 IN COMPLEX WITH GP130(PTYR757) PHOSPHOPEPTIDE.
557, d1bfjA_, 0.7521, 1.93, 0.337, 147, 95, SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE NMR MINIMIZED AVERAGE STRUCTURE
558, d5ibsA1, 0.7519, 1.93, 0.337, 147, 95, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
559, d5ibmA1, 0.7510, 1.65, 0.352, 109, 91, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
560, d5ehrB1, 0.7499, 1.81, 0.250, 95, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
561, p6bmwB2, 0.7497, 2.02, 0.315, 101, 92, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
562, p2lqnA1, 0.7493, 1.90, 0.333, 102, 93, SOLUTION STRUCTURE OF CRKL
563, d5ehpB2, 0.7474, 2.34, 0.311, 107, 103, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
564, p2lqwA1, 0.7443, 2.08, 0.245, 107, 94, SOLUTION STRUCTURE OF PHOSPHORYLATED CRKL
565, d1bfiA_, 0.7424, 1.63, 0.322, 96, 90, SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE NMR 30 STRUCTURES
566, p2cr4A_, 0.7420, 1.84, 0.315, 99, 92, SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN SH3BP2 PROTEIN
567, d1tceA1, 0.7415, 1.73, 0.322, 95, 90, SOLUTION NMR STRUCTURE OF THE SHC SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM THE T-CELL RECEPTOR MINIMIZED AVERAGE STRUCTURE
568, d1wquA1, 0.7405, 1.66, 0.333, 104, 90, SOLUTION STRUCTURE OF THE HUMAN FES SH2 DOMAIN
569, d2eyyA2, 0.7396, 1.96, 0.309, 100, 94, CT10-REGULATED KINASE ISOFORM I
570, d6bn5A2, 0.7348, 1.90, 0.247, 109, 93, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
571, d1picA_, 0.7334, 1.63, 0.322, 96, 90, PHOSPHATIDYLINOSITOL 3-KINASE P85-ALPHA SUBUNIT: C- TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR NMR MINIMIZED MEAN STRUCTURE
572, d1ab2A_, 0.7315, 1.57, 0.292, 94, 89, THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
573, d2eyvA2, 0.7309, 1.59, 0.297, 106, 91, SH2 DOMAIN OF CT10-REGULATED KINASE
574, d4ludB2, 0.7308, 1.59, 0.297, 106, 91, CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
575, p6bmxB3, 0.7306, 1.49, 0.330, 92, 88, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
576, d6bn5B1, 0.7298, 1.96, 0.309, 105, 94, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
577, d2dcrA1, 0.7281, 1.49, 0.330, 92, 88, FULLY AUTOMATED SOLUTION STRUCTURE DETERMINATION OF THE FES SH2 DOMAIN
578, d1x0nA_, 0.7258, 1.88, 0.261, 100, 92, NMR STRUCTURE OF GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH THE INHIBITOR
579, p2l6kA_, 0.7252, 2.00, 0.304, 101, 92, SOLUTION STRUCTURE OF A NONPHOSPHORYLATED PEPTIDE RECOGNIZING DOMAIN
580, d1fhsA_, 0.7245, 2.50, 0.301, 107, 103, THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY DOMAIN-2 OF THE GROWTH FACTOR RECEPTOR BOUND PROTEIN-2 NMR 18 STRUCTURES
581, p2el8A_, 0.7222, 1.70, 0.311, 95, 90, SOLUTION STRUCTURE OF THE HUMAN STAP2 SH2 DOMAIN
582, p3mazA_, 0.7218, 1.72, 0.326, 96, 89, CRYSTAL STRUCTURE OF THE HUMAN BRDG1/STAP-1 SH2 DOMAIN IN COMPLEX WITH THE NTAL PTYR136 PEPTIDE
583, d5bo4P1, 0.7204, 2.43, 0.297, 107, 101, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
584, d5bo4D1, 0.7187, 2.36, 0.204, 102, 98, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
585, d5bo4M1, 0.7181, 2.36, 0.204, 102, 98, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
586, d5bo4A1, 0.7147, 1.51, 0.307, 93, 88, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
587, p5uk8B1, 0.7141, 1.75, 0.283, 101, 92, THE CO-STRUCTURE OF (R)-4-(6-(1-(CYCLOPROPYLSULFONYL)CYCLOPROPYL)-2- (1H-INDOL-4-YL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
588, d2c9wA2, 0.7141, 1.97, 0.319, 100, 91, CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION
589, d5bo4J1, 0.7140, 2.09, 0.271, 119, 96, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
590, d5bo4G1, 0.7133, 2.12, 0.333, 111, 93, STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS
591, p5sxkB1, 0.7095, 1.81, 0.322, 98, 90, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 18
592, d2pleA1, 0.7091, 1.81, 0.322, 97, 90, NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE
593, p4wafB1, 0.7088, 1.67, 0.318, 95, 88, CRYSTAL STRUCTURE OF A NOVEL TETRAHYDROPYRAZOLO[15-A]PYRAZINE IN AN ENGINEERED PI3K ALPHA
594, d2pnbA_, 0.7031, 1.63, 0.315, 95, 89, STRUCTURE OF AN SH2 DOMAIN OF THE P85 ALPHA SUBUNIT OF PHOSPHATIDYLINOSITOL-3-OH KINASE
595, p4z32E3, 0.7011, 2.11, 0.351, 118, 94, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
596, d2pldA1, 0.7011, 1.50, 0.322, 92, 87, NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE
597, p5swrB1, 0.6995, 2.01, 0.362, 123, 94, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 20 AND 26
598, p4po6A3, 0.6978, 2.14, 0.333, 111, 93, CRYSTAL STRUCTURE OF THE HUMAN TYK2 FERM AND SH2 DOMAINS WITH AN IFNAR1 INTRACELLULAR PEPTIDE
599, p5swpB1, 0.6975, 2.28, 0.268, 113, 97, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
600, p5d39B3, 0.6889, 2.28, 0.268, 113, 97, TRANSCRIPTION FACTOR-DNA COMPLEX
601, p3gxwD_, 0.6883, 2.05, 0.333, 104, 93, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM A
602, p3gxwC_, 0.6876, 1.96, 0.301, 101, 93, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM A
603, p3gxwB_, 0.6873, 1.80, 0.363, 109, 91, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM A
604, p5d39A4, 0.6810, 1.63, 0.337, 90, 86, TRANSCRIPTION FACTOR-DNA COMPLEX
605, p3gxwA_, 0.6806, 2.43, 0.309, 112, 94, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM A
606, d2pnaA_, 0.6798, 2.43, 0.309, 112, 94, STRUCTURE OF AN SH2 DOMAIN OF THE P85 ALPHA SUBUNIT OF PHOSPHATIDYLINOSITOL-3-OH KINASE
607, p5d39D4, 0.6795, 2.39, 0.351, 109, 97, TRANSCRIPTION FACTOR-DNA COMPLEX
608, p4y5wA4, 0.6795, 2.25, 0.326, 119, 95, TRANSCRIPTION FACTOR-DNA COMPLEX
609, p4y5wB4, 0.6786, 0.99, 0.519, 83, 81, TRANSCRIPTION FACTOR-DNA COMPLEX
610, p3gxxA_, 0.6778, 1.50, 0.341, 89, 85, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM B
611, p3gxxB_, 0.6772, 1.62, 0.341, 90, 85, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM B
612, p1yvlB6, 0.6772, 2.12, 0.301, 101, 93, STRUCTURE OF UNPHOSPHORYLATED STAT1
613, d1bf5A3, 0.6754, 2.18, 0.341, 100, 91, TYROSINE PHOSPHORYLATED STAT-1/DNA COMPLEX
614, p1yvlA3, 0.6742, 2.53, 0.312, 115, 96, STRUCTURE OF UNPHOSPHORYLATED STAT1
615, d6bn5A1, 0.6729, 2.50, 0.309, 112, 94, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
616, p5vkoA2, 0.6722, 2.50, 0.309, 112, 94, SPT6 TSH2-RPB1 1468-1500 PT1471 PS1493
617, p4y5uB4, 0.6717, 2.52, 0.198, 103, 96, TRANSCRIPTION FACTOR
618, p4y5uA3, 0.6714, 2.52, 0.198, 103, 96, TRANSCRIPTION FACTOR
619, p5sxdB1, 0.6707, 2.48, 0.160, 99, 94, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 22
620, p5d39C4, 0.6706, 2.48, 0.160, 99, 94, TRANSCRIPTION FACTOR-DNA COMPLEX
621, p4z32C3, 0.6697, 1.81, 0.279, 102, 86, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
622, p2l3tA2, 0.6683, 1.82, 0.279, 102, 86, SOLUTION STRUCTURE OF TANDEM SH2 DOMAIN FROM SPT6
623, p4y5wC4, 0.6679, 1.82, 0.279, 102, 86, TRANSCRIPTION FACTOR-DNA COMPLEX
624, p5vklA2, 0.6676, 1.86, 0.291, 102, 86, SPT6 TSH2-RPB1 1476-1500 PS1493
625, p4y5wD4, 0.6670, 1.54, 0.345, 87, 84, TRANSCRIPTION FACTOR-DNA COMPLEX
626, d4jghA1, 0.6663, 1.90, 0.279, 103, 86, STRUCTURE OF THE SOCS2-ELONGIN BC COMPLEX BOUND TO AN N-TERMINAL FRAGMENT OF CULLIN5
627, p3pskA2, 0.6642, 1.90, 0.279, 103, 86, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
628, p3pjpB1, 0.6631, 1.85, 0.291, 102, 86, A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)
629, p3pjpA1, 0.6627, 1.87, 0.291, 102, 86, A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)
630, p3psjA1, 0.6622, 1.88, 0.310, 93, 87, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM SE-SPT6 (1247-1451)
631, d2ge9A_, 0.6619, 2.29, 0.269, 97, 93, SOLUTION STRUCTURES OF THE SH2 DOMAIN OF BRUTON S TYROSINE KINASE
632, p4zopB1, 0.6618, 1.92, 0.322, 91, 87, CO-CRYSTAL STRUCTURE OF LIPID KINASE PI3K ALPHA WITH A SELECTIVE PHOSPHATIDYLINOSITOL-3 KINASE ALPHA INHIBITOR
633, p3pjpA2, 0.6610, 2.29, 0.319, 104, 94, A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)
634, d1uurA3, 0.6610, 1.98, 0.225, 90, 89, STRUCTURE OF AN ACTIVATED DICTYOSTELIUM STAT IN ITS DNA-UNBOUND FORM
635, d1fu6A_, 0.6603, 2.38, 0.255, 97, 94, NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- KINASE
636, d1uusA3, 0.6598, 1.91, 0.329, 88, 85, STRUCTURE OF AN ACTIVATED DICTYOSTELIUM STAT IN ITS DNA-UNBOUND FORM
637, p3psjA2, 0.6597, 2.30, 0.183, 102, 93, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM SE-SPT6 (1247-1451)
638, p3pjpB2, 0.6590, 2.30, 0.183, 102, 93, A TANDEM SH2 DOMAIN IN TRANSCRIPTION ELONGATION FACTOR SPT6 BINDS THE PHOSPHORYLATED RNA POLYMERASE II C-TERMINAL REPEAT DOMAIN(CTD)
639, p3pskC1, 0.6575, 1.86, 0.294, 91, 85, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
640, p3pskD2, 0.6573, 2.02, 0.221, 111, 86, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
641, p5vklA1, 0.6571, 1.86, 0.165, 96, 85, SPT6 TSH2-RPB1 1476-1500 PS1493
642, d1bg1A3, 0.6567, 1.70, 0.167, 97, 84, TRANSCRIPTION FACTOR STAT3B/DNA COMPLEX
643, p3pskB2, 0.6552, 1.71, 0.167, 92, 84, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
644, p3pskB1, 0.6552, 2.17, 0.221, 111, 86, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
645, p5vkoA1, 0.6549, 1.73, 0.169, 91, 83, SPT6 TSH2-RPB1 1468-1500 PT1471 PS1493
646, p3zniI3, 0.6543, 2.29, 0.326, 104, 92, STRUCTURE OF PHOSPHOTYR363-CBL-B - UBCH5B-UB - ZAP-70 PEPTIDE COMPLEX
647, p3vrpA3, 0.6537, 2.20, 0.221, 112, 86, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C IN COMPLEX WITH PHOSPHO-EGFR PEPTIDE
648, p3vroA3, 0.6527, 2.21, 0.221, 112, 86, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C IN COMPLEX WITH PHOSPHO-SRC PEPTIDE
649, p3vrrA3, 0.6526, 2.39, 0.218, 112, 87, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C (PL MUTANT) IN COMPLEX WITH PHOSPHO-EGFR PEPTIDE
650, p3op0B3, 0.6523, 1.88, 0.165, 94, 85, CRYSTAL STRUCTURE OF CBL-C (CBL-3) TKB DOMAIN IN COMPLEX WITH EGFR PY1069 PEPTIDE
651, p3op0A3, 0.6523, 1.87, 0.165, 94, 85, CRYSTAL STRUCTURE OF CBL-C (CBL-3) TKB DOMAIN IN COMPLEX WITH EGFR PY1069 PEPTIDE
652, p5hkzA3, 0.6519, 2.55, 0.185, 123, 92, CRYSTAL STRUCTURE OF C-CBL TKBD IN COMPLEX WITH SPRY2 PEPTIDE (36-60 PY55) REFINED TO 1.8 A RESOLUTION (P21 FORM)
653, p3zniE3, 0.6515, 2.44, 0.187, 125, 91, STRUCTURE OF PHOSPHOTYR363-CBL-B - UBCH5B-UB - ZAP-70 PEPTIDE COMPLEX
654, p3zniM3, 0.6514, 2.42, 0.180, 121, 89, STRUCTURE OF PHOSPHOTYR363-CBL-B - UBCH5B-UB - ZAP-70 PEPTIDE COMPLEX
655, p3zniA3, 0.6511, 1.68, 0.354, 86, 79, STRUCTURE OF PHOSPHOTYR363-CBL-B - UBCH5B-UB - ZAP-70 PEPTIDE COMPLEX
656, p5swtB1, 0.6510, 2.18, 0.115, 97, 87, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 17 AND 27
657, p3pskD1, 0.6510, 2.25, 0.221, 106, 86, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
658, p1y1uC5, 0.6485, 2.26, 0.221, 121, 86, STRUCTURE OF UNPHOSPHORYLATED STAT5A
659, p3pskA1, 0.6484, 2.26, 0.221, 121, 86, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
660, p1y1uB5, 0.6483, 2.18, 0.325, 85, 83, STRUCTURE OF UNPHOSPHORYLATED STAT5A
661, p1y1uA5, 0.6483, 2.14, 0.224, 110, 85, STRUCTURE OF UNPHOSPHORYLATED STAT5A
662, p4a4bA3, 0.6482, 1.95, 0.250, 85, 84, STRUCTURE OF MODIFIED PHOSPHOTYR371-C-CBL-UBCH5B-ZAP-70 COMPLEX
663, p3pskC2, 0.6482, 2.14, 0.103, 103, 87, CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE FORM NATIVE SPT6 (1247-1451)
664, p5hl0A3, 0.6472, 2.03, 0.229, 108, 83, CRYSTAL STRUCTURE OF C-CBL TKBD IN COMPLEX WITH SPRY2 PEPTIDE (54-60 PY55) REFINED TO 2.2A RESOLUTION
665, p4e68A3, 0.6469, 2.23, 0.115, 97, 87, UNPHOSPHORYLATED STAT3B CORE PROTEIN BINDING TO DSDNA
666, p3gxxD_, 0.6467, 2.03, 0.229, 108, 83, STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6 CRYSTAL FORM B
667, p3pfvA3, 0.6464, 2.23, 0.279, 103, 86, CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH EGFR PY1069 PEPTIDE
668, p5itdB1, 0.6462, 2.48, 0.101, 99, 89, CRYSTAL STRUCTURE OF PI3K ALPHA WITH PI3K DELTA INHIBITOR
669, p4a4cA3, 0.6462, 2.02, 0.195, 91, 82, STRUCTURE OF PHOSPHOTYR371-C-CBL-UBCH5B-ZAP-70 COMPLEX
670, p3pfvB3, 0.6460, 1.97, 0.195, 90, 82, CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH EGFR PY1069 PEPTIDE
671, p2eyzA2, 0.6448, 1.99, 0.222, 90, 81, CT10-REGULATED KINASE ISOFORM II
672, p3ob2B3, 0.6445, 2.64, 0.234, 118, 94, CRYSTAL STRUCTURE OF C-CBL TKB DOMAIN IN COMPLEX WITH DOUBLE PHOSPHORYLATED EGFR PEPTIDE
673, p3ob1B3, 0.6442, 2.64, 0.234, 118, 94, CRYSTAL STRUCTURE OF C-CBL TKB DOMAIN IN COMPLEX WITH DOUBLE PHOSPHORYLATED SPRY2 PEPTIDE
674, p5ixiA2, 0.6418, 1.61, 0.346, 82, 78, STRUCTURE OF HUMAN JAK1 FERM/SH2 IN COMPLEX WITH IFNLR1/IL10RA CHIMERA
675, p5o76C3, 0.6417, 2.63, 0.124, 104, 89, STRUCTURE OF PHOSPHOY371 C-CBL IN COMPLEX WITH ZAP70-PEPTIDE AND UBV.PCBL UBIQUITIN VARIANT
676, p5hkyA3, 0.6410, 2.63, 0.124, 104, 89, CRYSTAL STRUCTURE OF C-CBL TKBD DOMAIN IN COMPLEX WITH SPRY2 PEPTIDE (36-60 PY55) REFINED TO 1.8A RESOLUTION (P6 FORM)
677, p5j3xA3, 0.6405, 2.16, 0.193, 130, 83, STRUCTURE OF C-CBL Y371F
678, d4u17C1, 0.6400, 2.16, 0.193, 130, 83, SWAPPED DIMER OF THE HUMAN FYN-SH2 DOMAIN
679, p4z32D3, 0.6391, 2.77, 0.301, 111, 93, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
680, p4ovvB1, 0.6384, 2.59, 0.186, 130, 86, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH DIC4-PIP2
681, p3plfD3, 0.6381, 2.54, 0.114, 97, 88, REVERSE BINDING MODE OF METRD PEPTIDE COMPLEXED WITH C-CBL TKB DOMAIN
682, p3cblA1, 0.6373, 2.65, 0.124, 104, 89, CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
683, d4u17A1, 0.6351, 2.01, 0.207, 90, 82, SWAPPED DIMER OF THE HUMAN FYN-SH2 DOMAIN
684, p5axiB3, 0.6339, 2.13, 0.095, 93, 84, CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH CBLIN
685, p3cd3A1, 0.6339, 2.05, 0.222, 92, 81, CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
686, d2dx0B_, 0.6339, 2.86, 0.204, 127, 93, CRYSTAL STRUCTURE OF THE N-TERMINAL SH2 DOMAIN OF MOUSE PHOSPHOLIPASE C-GAMMA 2
687, p3plfB3, 0.6333, 2.67, 0.101, 99, 89, REVERSE BINDING MODE OF METRD PEPTIDE COMPLEXED WITH C-CBL TKB DOMAIN
688, p5o76A3, 0.6329, 2.12, 0.220, 100, 82, STRUCTURE OF PHOSPHOY371 C-CBL IN COMPLEX WITH ZAP70-PEPTIDE AND UBV.PCBL UBIQUITIN VARIANT
689, d4u17B1, 0.6327, 2.04, 0.222, 92, 81, SWAPPED DIMER OF THE HUMAN FYN-SH2 DOMAIN
690, p5axiC3, 0.6290, 2.03, 0.171, 98, 82, CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH CBLIN
691, d1mw4A1, 0.6276, 2.04, 0.159, 92, 82, SOLUTION STRUCTURE OF THE HUMAN GRB7-SH2 DOMAIN IN COMPLEX WITH A 10 AMINO ACID PEPTIDE PY1139
692, p5axiA3, 0.6270, 2.05, 0.159, 92, 82, CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH CBLIN
693, p6bk5A3, 0.6260, 2.05, 0.159, 89, 82, INACTIVE CHOANOFLAGELLATE E3 UBIQUITIN LIGASE CBL TKB
694, p4yknA1, 0.6254, 2.04, 0.159, 114, 82, PI3K ALPHA LIPID KINASE WITH ACTIVE SITE INHIBITOR
695, d4gplB3, 0.6251, 2.04, 0.159, 114, 82, STRUCTURE OF CBL(TKB) BOUND TO A PHOSPHORYLATED PENTAPEPTIDE
696, d2cblA3, 0.6225, 2.06, 0.159, 92, 82, N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70
697, d3bumB3, 0.6215, 2.06, 0.171, 110, 82, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SPROUTY2
698, d3bunB3, 0.6202, 2.06, 0.171, 96, 82, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SPROUTY4
699, d1yvhA3, 0.6200, 2.05, 0.171, 98, 82, CRYSTAL STRUCTURE OF THE C-CBL TKB DOMAIN IN COMPLEX WITH THE APS PTYR-618 PHOSPHOPEPTIDE
700, d1fbvA3, 0.6198, 1.74, 0.333, 84, 78, STRUCTURE OF A CBL-UBCH7 COMPLEX: RING DOMAIN FUNCTION IN UBIQUITIN-PROTEIN LIGASES
701, p6dm3B_, 0.6191, 2.07, 0.207, 90, 82, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA; APOPROTEIN 
702, p6dm4D_, 0.6190, 2.55, 0.224, 115, 85, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA IN COMPLEX WITH HOMO SAPIENS SHC1 PHOSPHO- TYR317 PEPTIDE 
703, p5sx8B1, 0.6190, 2.18, 0.220, 100, 82, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 12 AND 15
704, d3buwD3, 0.6190, 2.18, 0.220, 100, 82, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SYK
705, p6dm4B_, 0.6189, 2.56, 0.224, 115, 85, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA IN COMPLEX WITH HOMO SAPIENS SHC1 PHOSPHO- TYR317 PEPTIDE 
706, p6dm4A_, 0.6181, 2.56, 0.224, 115, 85, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA IN COMPLEX WITH HOMO SAPIENS SHC1 PHOSPHO- TYR317 PEPTIDE 
707, p2y1nC3, 0.6180, 2.56, 0.224, 115, 85, STRUCTURE OF C-CBL-ZAP-70 PEPTIDE COMPLEX
708, d3buxB3, 0.6178, 2.10, 0.159, 110, 82, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN C-MET
709, d3vrqB2, 0.6177, 2.25, 0.106, 95, 85, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C (PL MUTANT)
710, d3s9kA1, 0.6176, 2.11, 0.159, 92, 82, CRYSTAL STRUCTURE OF THE ITK SH2 DOMAIN.
711, d3buxD3, 0.6172, 2.81, 0.187, 137, 91, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN C-MET
712, d3vrnA3, 0.6171, 2.81, 0.187, 137, 91, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C
713, d3buwB3, 0.6169, 1.87, 0.187, 85, 80, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SYK
714, p2y1mB3, 0.6168, 2.12, 0.171, 95, 82, STRUCTURE OF NATIVE C-CBL
715, p5j3xF3, 0.6166, 1.68, 0.364, 79, 77, STRUCTURE OF C-CBL Y371F
716, d3vrqA2, 0.6166, 2.14, 0.159, 110, 82, CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C (PL MUTANT)
717, d1b47B3, 0.6164, 2.12, 0.171, 111, 82, STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70
718, p6dm4C_, 0.6149, 2.64, 0.333, 142, 90, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA IN COMPLEX WITH HOMO SAPIENS SHC1 PHOSPHO- TYR317 PEPTIDE 
719, p2y1nA3, 0.6148, 2.15, 0.171, 91, 82, STRUCTURE OF C-CBL-ZAP-70 PEPTIDE COMPLEX
720, p5j3xB3, 0.6143, 2.16, 0.171, 91, 82, STRUCTURE OF C-CBL Y371F
721, p2y1mA3, 0.6141, 2.21, 0.190, 89, 84, STRUCTURE OF NATIVE C-CBL
722, p2xp1A1, 0.6137, 2.12, 0.159, 98, 82, STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6
723, p5j3xC3, 0.6127, 2.19, 0.171, 91, 82, STRUCTURE OF C-CBL Y371F
724, p3vgoB3, 0.6127, 2.15, 0.171, 98, 82, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT OF CBL-B
725, p2y1mC3, 0.6121, 1.84, 0.699, 101, 73, STRUCTURE OF NATIVE C-CBL
726, p2y1mE3, 0.6113, 1.85, 0.253, 80, 79, STRUCTURE OF NATIVE C-CBL
727, p4z32H3, 0.6107, 2.12, 0.350, 83, 80, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
728, p2y1mF3, 0.6102, 2.20, 0.159, 91, 82, STRUCTURE OF NATIVE C-CBL
729, p2bbuA1, 0.6101, 1.63, 0.351, 87, 77, SOLUTION STRUCTURE OF MOUSE SOCS3 IN COMPLEX WITH A PHOSPHOPEPTIDE FROM THE GP130 RECEPTOR
730, p5j3xD3, 0.6094, 1.86, 0.685, 101, 73, STRUCTURE OF C-CBL Y371F
731, p2y1mD3, 0.6094, 2.21, 0.171, 91, 82, STRUCTURE OF NATIVE C-CBL
732, p2xp1A2, 0.6089, 1.68, 0.338, 88, 77, STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6
733, p5hkxA3, 0.6087, 1.49, 0.365, 95, 74, CRYSTAL STRUCTURE OF C-CBL TKBD-RING DOMAINS (Y371E MUTANT) REFINED TO 1.85 A RESOLUTION
734, p5j3xE3, 0.6086, 2.25, 0.171, 90, 82, STRUCTURE OF C-CBL Y371F
735, p3vgoC3, 0.6084, 2.21, 0.171, 94, 82, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT OF CBL-B
736, d3vgoA3, 0.6081, 1.61, 0.694, 101, 72, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT OF CBL-B
737, d1b47C3, 0.6077, 2.28, 0.171, 89, 82, STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70
738, d3buoD3, 0.6076, 3.16, 0.268, 118, 97, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN EGF RECEPTOR 
739, d3buoB3, 0.6076, 3.16, 0.268, 118, 97, CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN EGF RECEPTOR 
740, d5hkwA3, 0.6071, 2.32, 0.171, 92, 82, CRYSTAL STRUCTURE OF APO C-CBL TKBD REFINED TO 2.25 A RESOLUTION
741, d2ewnB3, 0.6064, 2.36, 0.159, 122, 82, ECOLI BIOTIN REPRESSOR WITH CO-REPRESSOR ANALOG
742, d1b47A3, 0.6050, 2.36, 0.159, 122, 82, STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70
743, p2l4kA_, 0.6042, 1.79, 0.320, 75, 75, WATER REFINED SOLUTION STRUCTURE OF THE HUMAN GRB7-SH2 DOMAIN IN COMPLEX WITH THE 10 AMINO ACID PEPTIDE PY1139
744, d2ewnA3, 0.6030, 2.11, 0.165, 88, 79, ECOLI BIOTIN REPRESSOR WITH CO-REPRESSOR ANALOG
745, d1fu5A_, 0.6025, 2.14, 0.165, 88, 79, NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN
746, d1rqqC_, 0.6022, 2.16, 0.165, 88, 79, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
747, p3cwgB4, 0.6021, 2.14, 0.165, 88, 79, UNPHOSPHORYLATED MOUSE STAT3 CORE FRAGMENT
748, p6dm3A_, 0.6017, 2.15, 0.165, 88, 79, CRYSTAL STRUCTURE OF THE SH2 DOMAIN FROM RAVO (LPG1129) FROM LEGIONELLA PNEUMOPHILA; APOPROTEIN 
749, d1rqqD_, 0.6016, 2.17, 0.165, 92, 79, CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
750, d5hkwB3, 0.6002, 2.90, 0.115, 108, 87, CRYSTAL STRUCTURE OF APO C-CBL TKBD REFINED TO 2.25 A RESOLUTION
751, d5hkwC3, 0.5993, 3.24, 0.122, 119, 90, CRYSTAL STRUCTURE OF APO C-CBL TKBD REFINED TO 2.25 A RESOLUTION
752, d2c7iA_, 0.5976, 1.91, 0.289, 82, 76, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM.
753, d1hxdB3, 0.5975, 2.19, 0.165, 88, 79, CRYSTAL STRUCTURE OF E. COLI BIOTIN REPRESSOR WITH BOUND BIOTIN
754, d2c7iB_, 0.5956, 2.96, 0.114, 119, 88, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM.
755, d2c8mB_, 0.5947, 3.12, 0.124, 119, 89, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM WITH BOUND LIPOIC ACID
756, d1rpyA_, 0.5938, 2.10, 0.167, 94, 78, CRYSTAL STRUCTURE OF THE DIMERIC SH2 DOMAIN OF APS
757, d2aruA_, 0.5937, 2.17, 0.165, 88, 79, CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A BOUND WITH ATP
758, d3r07A1, 0.5936, 2.13, 0.165, 87, 79, STRUCTURAL ANALYSIS OF AN ARCHAEAL LIPOYLATION SYSTEM. A BI-PARTITE LIPOATE PROTEIN LIGASE AND ITS E2 LIPOYL DOMAIN FROM THERMOPLASMA ACIDOPHILUM
759, d1rpyB_, 0.5934, 1.85, 0.324, 106, 74, CRYSTAL STRUCTURE OF THE DIMERIC SH2 DOMAIN OF APS
760, d4wf2A2, 0.5929, 2.17, 0.165, 88, 79, STRUCTURE OF E. COLI BIRA G142A BOUND TO BIOTINOL-5 -AMP
761, d2c7iD_, 0.5917, 2.18, 0.165, 87, 79, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM.
762, p4z32G3, 0.5915, 2.20, 0.165, 88, 79, CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2
763, p5cdwL_, 0.5913, 2.11, 0.167, 82, 78, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
764, d1hxdA3, 0.5909, 2.07, 0.167, 94, 78, CRYSTAL STRUCTURE OF E. COLI BIOTIN REPRESSOR WITH BOUND BIOTIN
765, d1bibA3, 0.5905, 2.13, 0.165, 87, 79, THE E. COLI BIOTIN HOLOENZYME SYNTHETASE(SLASH)BIO REPRESSOR CRYSTAL STRUCTURE DELINEATES THE BIOTIN AND DNA- BINDING DOMAINS
766, d2c7iC_, 0.5904, 2.15, 0.165, 87, 79, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM.
767, p5cdwC_, 0.5896, 3.29, 0.121, 119, 91, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
768, p5cdwE_, 0.5893, 2.14, 0.167, 91, 78, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
769, d1fyrC_, 0.5888, 2.09, 0.167, 83, 78, DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX
770, p5cdwH_, 0.5883, 2.08, 0.167, 91, 78, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
771, p4ha8A2, 0.5846, 2.31, 0.190, 88, 79, STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH BIOTIN ACETYLENE
772, d2aobA_, 0.5845, 2.31, 0.190, 88, 79, CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN
773, d1fyrA_, 0.5845, 2.13, 0.167, 82, 78, DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX
774, p3l1aA_, 0.5843, 2.27, 0.175, 82, 80, STRUCTURAL ORDERING OF DISORDERED LIGAND BINDING LOOPS OF BIOTIN PROTEIN LIGASE INTO ACTIVE CONFORMATIONS AS A CONSEQUENCE OF DEHYDRATION
775, d2c8mA_, 0.5840, 2.12, 0.167, 92, 78, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM WITH BOUND LIPOIC ACID
776, d2aobC_, 0.5840, 2.13, 0.167, 90, 78, CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN
777, p3v7cA2, 0.5838, 1.75, 0.253, 76, 75, CYSTAL STRUCTURE OF SABPL IN COMPLEX WITH INHIBITOR
778, p4dq2A2, 0.5835, 2.15, 0.167, 91, 78, STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH BIOTINOL-5 -AMP
779, d2artA_, 0.5834, 2.91, 0.231, 119, 91, CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A BOUND WITH LIPOYL-AMP
780, p3v8lA2, 0.5833, 2.10, 0.167, 83, 78, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH BIOTINYL-5 -AMP
781, p3rirA2, 0.5833, 2.14, 0.167, 92, 78, CRYSTAL STRUCRTURE OF BIOTIN PROTEIN LIGASE FROM S. AUREUS
782, p5cdwV_, 0.5830, 2.16, 0.162, 87, 80, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
783, d1z3kA_, 0.5830, 2.16, 0.162, 87, 80, STRUCTURAL INSIGHT INTO THE BINDING DIVERSITY BETWEEN THE TYR-PHOSPHORYLATED HUMAN EPHRINBS AND NCK2 SH2 DOMAIN
784, d1fyrB_, 0.5828, 2.15, 0.167, 82, 78, DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX
785, p3rkyA2, 0.5818, 2.13, 0.167, 92, 78, STRUCTURAL CHARACTERISATION OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE
786, d2c8mC_, 0.5817, 2.28, 0.175, 94, 80, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM WITH BOUND LIPOIC ACID
787, p4xu3B1, 0.5815, 2.24, 0.177, 84, 79, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 90 THAT HAS AN ACYCLIC ETHER IN PLACE OF THE RIBOSE
788, p4xtwB1, 0.5809, 2.25, 0.165, 87, 79, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 46 WITH AZIDE IN PLACE OF 2 OH
789, d1xa6A2, 0.5807, 2.27, 0.165, 88, 79, CRYSTAL STRUCTURE OF THE HUMAN BETA2-CHIMAERIN
790, p4xu1A1, 0.5800, 2.27, 0.165, 88, 79, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 82 THAT INCORPORATES A MORPHOLINE IN PLACE OF THE RIBOSE
791, d2h5kB1, 0.5798, 2.25, 0.165, 86, 79, CRYSTAL STRUCTURE OF COMPLEX BETWEEN THE DOMAIN-SWAPPED DIMERIC GRB2 SH2 DOMAIN AND SHC-DERIVED LIGAND AC-NH-PTYR-VAL-ASN-NH2
792, d2c8mD_, 0.5795, 3.38, 0.100, 207, 90, STRUCTURE OF PROTEIN TA0514 PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM WITH BOUND LIPOIC ACID
793, p4xtvA1, 0.5792, 2.27, 0.165, 87, 79, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 36 (N-({[(1R3S)-3-(6-AMINO-9H-PURIN-9-YL) CYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS4S6AR)-2-OXOHEXAHYDRO-1H- THIENO[34-D]IMIDAZOL-4-YL]PENTANAMIDE)
794, d2aoaA_, 0.5791, 3.45, 0.268, 109, 97, CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN
795, d2arsA1, 0.5790, 3.37, 0.100, 207, 90, CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A FROM THERMOPLASMA ACIDOPHILUM
796, p3ruxB1, 0.5789, 3.37, 0.100, 207, 90, CRYSTAL STRUCTURE OF BIOTIN-PROTEIN LIGASE BIRA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN ACYLSULFAMIDE BISUBSTRATE INHIBITOR
797, p5cdwP_, 0.5786, 3.15, 0.280, 111, 93, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
798, p4jpsB1, 0.5786, 3.15, 0.280, 111, 93, CO-CRYSTAL STRUCTURES OF THE LIPID KINASE PI3K ALPHA WITH PAN AND ISOFORM SELECTIVE INHIBITORS
799, p3ruxA1, 0.5785, 2.53, 0.208, 83, 77, CRYSTAL STRUCTURE OF BIOTIN-PROTEIN LIGASE BIRA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN ACYLSULFAMIDE BISUBSTRATE INHIBITOR
800, p5cdwZ_, 0.5783, 2.74, 0.232, 108, 82, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
801, p4xu3A1, 0.5783, 2.73, 0.120, 108, 83, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 90 THAT HAS AN ACYCLIC ETHER IN PLACE OF THE RIBOSE
802, p4xtyB1, 0.5783, 2.53, 0.208, 83, 77, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 63 WITH FLUORINE IN PLACE OF 2 OH
803, p2e5aA1, 0.5782, 2.32, 0.165, 86, 79, CRYSTAL STRUCTURE OF BOVINE LIPOYLTRANSFERASE IN COMPLEX WITH LIPOYL-AMP
804, p4xtwA1, 0.5781, 2.32, 0.165, 86, 79, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 46 WITH AZIDE IN PLACE OF 2 OH
805, p4xu1B1, 0.5779, 2.88, 0.093, 244, 86, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 82 THAT INCORPORATES A MORPHOLINE IN PLACE OF THE RIBOSE
806, p4xtyA1, 0.5779, 3.02, 0.115, 198, 87, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 63 WITH FLUORINE IN PLACE OF 2 OH
807, p5cdwd_, 0.5777, 3.09, 0.091, 240, 88, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
808, p4xtxB1, 0.5775, 2.91, 0.093, 245, 86, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 57 WITH AZIDE IN PLACE OF RIBOSE 2 OH
809, p3a7uA1, 0.5773, 2.45, 0.211, 81, 76, CRYSTAL STRUCTURE OF THE BOVINE LIPOYLTRANSFERASE IN ITS UNLIGANDED FORM
810, d2fciA1, 0.5773, 2.97, 0.092, 247, 87, STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE
811, p4xu0A1, 0.5772, 3.13, 0.091, 254, 88, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 73 THAT HAS A 2 -METHYL ON THE RIBOSE
812, p4xu2A1, 0.5770, 3.13, 0.091, 254, 88, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 87 WITH A 3 DEOXY RIBOSE
813, p4op0B1, 0.5770, 2.31, 0.216, 85, 74, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE (RV3279C) OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH BIOTINYL-5 -AMP
814, p4xtuA1, 0.5769, 3.18, 0.114, 193, 88, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR (N-({[(1R2S3R4R)-4-(6-AMINO-9H-PURIN-9-YL)-23- DIHYDROXYCYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS4S6AR)-2- OXOHEXAHYDRO-1H-THIENO[34-D]IMIDAZOL-4-YL]PENTANAMIDE)
815, p4xtxA1, 0.5767, 2.95, 0.092, 240, 87, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 57 WITH AZIDE IN PLACE OF RIBOSE 2 OH
816, p4xu2B1, 0.5766, 1.93, 0.257, 75, 74, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 87 WITH A 3 DEOXY RIBOSE
817, p4xtzA1, 0.5762, 1.73, 0.343, 67, 67, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 69 THAT HAS A FLUORINE IN PLACE OF THE RIBOSE 2 OH
818, d3a7rA1, 0.5762, 3.48, 0.101, 198, 89, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH LIPOYL-AMP.
819, d2h5kA1, 0.5753, 3.06, 0.115, 185, 87, CRYSTAL STRUCTURE OF COMPLEX BETWEEN THE DOMAIN-SWAPPED DIMERIC GRB2 SH2 DOMAIN AND SHC-DERIVED LIGAND AC-NH-PTYR-VAL-ASN-NH2
820, d2h46E_, 0.5738, 2.95, 0.092, 240, 87, NATIVE DOMAIN-SWAPPED DIMER CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN
821, d3a7aC1, 0.5732, 1.69, 0.343, 67, 67, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH OCTYL-AMP AND APOH-PROTEIN
822, p2qhtA_, 0.5730, 1.71, 0.343, 67, 67, STRUCTURAL BASIS OF OCTANOIC ACID RECOGNITION BY LIPOATE-PROTEIN LIGASE B
823, p2qhsA_, 0.5728, 2.27, 0.324, 98, 71, STRUCTURAL BASIS OF OCTANOIC ACID RECOGNITION BY LIPOATE-PROTEIN LIGASE B
824, p2qhvA_, 0.5727, 1.42, 0.348, 66, 66, STRUCTURAL BASIS OF OCTANOIC ACID RECOGNITION BY LIPOATE-PROTEIN LIGASE B
825, p2qhuA_, 0.5724, 3.32, 0.101, 212, 89, STRUCTURAL BASIS OF OCTANOIC ACID RECOGNITION BY LIPOATE-PROTEIN LIGASE B
826, p4tvwC1, 0.5721, 1.91, 0.329, 96, 70, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
827, p4op0A1, 0.5717, 1.61, 0.343, 95, 67, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE (RV3279C) OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH BIOTINYL-5 -AMP
828, d3a7aA1, 0.5717, 3.58, 0.067, 264, 89, CRYSTAL STRUCTURE OF E. COLI LIPOATE-PROTEIN LIGASE A IN COMPLEX WITH OCTYL-AMP AND APOH-PROTEIN
829, p2cghB1, 0.5716, 3.58, 0.067, 264, 89, CRYSTAL STRUCTURE OF BIOTIN LIGASE FROM MYCOBACTERIUM TUBERCULOSIS
830, p5t8uA1, 0.5714, 3.65, 0.108, 241, 93, CRYSTAL STRUCTURE OF P. FALCIPARUM LIPL1 IN COMPLEX LIPOATE
831, d5iclB1, 0.5712, 2.08, 0.324, 96, 71, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH LIPOYL-AMP
832, d5iclA1, 0.5708, 3.31, 0.101, 212, 89, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH LIPOYL-AMP
833, d5ibyA1, 0.5708, 3.36, 0.101, 212, 89, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH LIPOIC ACID
834, d5ichA1, 0.5703, 3.66, 0.097, 247, 93, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH 8BO-AMP
835, p4tvwA1, 0.5700, 3.50, 0.100, 212, 90, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
836, p4tvwB1, 0.5698, 3.33, 0.101, 212, 89, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
837, p5cdwc_, 0.5695, 3.33, 0.101, 212, 89, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
838, p4tvwD1, 0.5692, 1.26, 0.354, 66, 65, RESORUFIN LIGASE WITH BOUND RESORUFIN-AMP ANALOG
839, p3cxlA4, 0.5691, 3.47, 0.250, 98, 88, CRYSTAL STRUCTURE OF HUMAN CHIMERIN 1 (CHN1)
840, d1fyrD_, 0.5687, 1.71, 0.338, 98, 68, DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX
841, p5cdwB_, 0.5661, 3.32, 0.101, 212, 89, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
842, p5cdwO_, 0.5659, 3.78, 0.096, 245, 94, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
843, p5cdwA_, 0.5650, 2.92, 0.105, 213, 86, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
844, p5t8uB1, 0.5644, 2.93, 0.105, 210, 86, CRYSTAL STRUCTURE OF P. FALCIPARUM LIPL1 IN COMPLEX LIPOATE
845, p4jmgA1, 0.5644, 2.64, 0.173, 141, 81, CRYSTAL STRUCTURE OF THE SYNTHETIC PROTEIN IN COMPLEX WITH PY PEPTIDE
846, d5idhA1, 0.5638, 2.64, 0.173, 141, 81, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH 8-BROMOOCTANOIC ACID
847, d2p5iA1, 0.5638, 3.49, 0.080, 215, 88, CRYSTAL STRUCTURE OF PROTEIN BH3822 FROM BACILLUS HALODURANS A MEMBER OF THE BIOTIN/LIPOATE A/B PROTEIN LIGASE FAMILY
848, p3efrA1, 0.5635, 1.74, 0.338, 96, 68, BIOTIN PROTEIN LIGASE R40G MUTANT FROM AQUIFEX AEOLICUS IN COMPLEX WITH BIOTIN
849, p2cghA1, 0.5634, 3.83, 0.096, 241, 94, CRYSTAL STRUCTURE OF BIOTIN LIGASE FROM MYCOBACTERIUM TUBERCULOSIS
850, p5cdwY_, 0.5625, 3.49, 0.080, 216, 88, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
851, p3efrB1, 0.5619, 2.09, 0.333, 93, 69, BIOTIN PROTEIN LIGASE R40G MUTANT FROM AQUIFEX AEOLICUS IN COMPLEX WITH BIOTIN
852, p5cdwU_, 0.5618, 3.70, 0.098, 232, 92, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
853, p3v8kA2, 0.5618, 3.46, 0.080, 212, 88, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH BIOTIN
854, p3l2zB1, 0.5617, 1.34, 0.354, 65, 65, CRYSTAL STRUCTURE OF HYDRATED BIOTIN PROTEIN LIGASE FROM M. TUBERCULOSIS
855, d1w66A1, 0.5617, 1.50, 0.343, 69, 67, STRUCTURE OF A LIPOATE-PROTEIN LIGASE B FROM MYCOBACTERIUM TUBERCULOSIS
856, p5cdwK_, 0.5614, 3.49, 0.080, 216, 88, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT GRB2 SH2 DOMAIN (W121G) WITH A PYVNV PEPTIDE
857, d1biaA3, 0.5611, 1.36, 0.354, 66, 65, THE E. COLI BIOTIN HOLOENZYME SYNTHETASE(SLASH)BIO REPRESSOR CRYSTAL STRUCTURE DELINEATES THE BIOTIN AND DNA- BINDING DOMAINS
858, p3l2zA1, 0.5609, 3.50, 0.080, 214, 88, CRYSTAL STRUCTURE OF HYDRATED BIOTIN PROTEIN LIGASE FROM M. TUBERCULOSIS
859, p2ej9A1, 0.5608, 3.46, 0.080, 212, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM METHANOCOCCUS JANNASCHII
860, p3v7rA2, 0.5593, 3.46, 0.080, 249, 88, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH INHIBITOR
861, d1q88B1, 0.5592, 3.46, 0.080, 249, 88, CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN IBP39 (MONOCLINIC FORM)
862, d2aobD_, 0.5585, 3.50, 0.080, 217, 88, CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN
863, d5ichB1, 0.5582, 3.47, 0.068, 214, 88, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-2) IN COMPLEX WITH 8BO-AMP
864, d4tvyB1, 0.5581, 3.50, 0.080, 216, 88, APO RESORUFIN LIGASE
865, d5ij6A1, 0.5573, 1.30, 0.354, 67, 65, CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS LIPOATE-PROTEIN LIGASE A (LPLA-1) IN COMPLEX WITH LIPOIC ACID
866, p5sx9B1, 0.5571, 3.45, 0.068, 214, 88, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
867, d4tvyA1, 0.5569, 3.45, 0.080, 229, 88, APO RESORUFIN LIGASE
868, p3v7sA2, 0.5569, 3.05, 0.233, 97, 86, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH INHIBITOR 0364
869, p3rkwA2, 0.5559, 3.51, 0.080, 216, 88, STRUCTURAL CHARACTERISATION OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE
870, p3efsB1, 0.5557, 3.50, 0.080, 213, 88, BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH BIOTIN AND ATP
871, p6apwA2, 0.5554, 3.74, 0.078, 209, 90, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH INHIBITOR
872, p5sxeB1, 0.5539, 3.50, 0.080, 217, 88, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 19 AND 28
873, p4jmhA1, 0.5520, 3.53, 0.080, 217, 88, CRYSTAL STRUCTURE OF SYNTHETIC PROTEIN IN COMPLEX WITH DOUBLE PY PEPTIDE
874, d1vqzA2, 0.5510, 3.47, 0.068, 209, 88, CRYSTAL STRUCTURE OF A PUTATIVE LIPOATE-PROTEIN LIGASE A (SP_1160) FROM STREPTOCOCCUS PNEUMONIAE TIGR4 AT 1.99 A RESOLUTION
875, d2djzA1, 0.5508, 3.52, 0.080, 217, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP K111A MUTATION
876, d1wq7A2, 0.5504, 3.53, 0.090, 246, 89, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3
877, d2ejgB1, 0.5503, 1.79, 0.338, 96, 68, CRYSTAL STRUCTURE OF THE BIOTIN PROTEIN LIGASE (MUTATION R48A) AND BIOTIN CARBOXYL CARRIER PROTEIN COMPLEX FROM PYROCOCCUS HORIKOSHII OT3
878, d2aobB_, 0.5502, 1.81, 0.338, 98, 68, CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN
879, d2e41A2, 0.5494, 3.53, 0.090, 246, 89, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH THE REACTION PRODUCT ANALOG BIOTINOL-5 -AMP MUTATIONS R48A AND K111A
880, d1x01A2, 0.5494, 3.72, 0.078, 210, 90, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ATP
881, d1wpyA2, 0.5493, 3.72, 0.078, 210, 90, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN
882, d2ejfB2, 0.5484, 3.72, 0.078, 210, 90, CRYSTAL STRUCTURE OF THE BIOTIN PROTEIN LIGASE (MUTATIONS R48A AND K111A) AND BIOTIN CARBOXYL CARRIER PROTEIN COMPLEX FROM PYROCOCCUS HORIKOSHII OT3
883, d1x2hA2, 0.5483, 3.73, 0.078, 210, 90, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI COMPLEXED WITH LIPOIC ACID
884, d2dthB2, 0.5481, 3.73, 0.078, 210, 90, THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN AND ADP
885, d2dthA2, 0.5481, 3.43, 0.080, 251, 88, THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN AND ADP
886, d2fykA2, 0.5478, 3.42, 0.080, 211, 87, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ADP AND BIOTIN
887, d1wnlA2, 0.5476, 3.58, 0.090, 246, 89, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ADP
888, d1jyuA1, 0.5475, 3.23, 0.103, 194, 87, XRAY STRUCTURE OF GRB2 SH2 DOMAIN
889, d1wpyB2, 0.5470, 3.49, 0.138, 246, 87, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN
890, p3efsA1, 0.5469, 3.22, 0.128, 231, 86, BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH BIOTIN AND ATP
891, d2dtoA2, 0.5469, 3.23, 0.128, 230, 86, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 COMPLEXED WITH ATP AND BIOTIN
892, d2dxuA1, 0.5467, 3.23, 0.128, 230, 86, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH BIOTINYL-5 -AMP MUTATION R48A
893, d2dxtA1, 0.5467, 3.22, 0.128, 231, 86, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH ATP AND BIOTIN MUTATION D104A
894, d1wqwA2, 0.5465, 3.56, 0.079, 251, 89, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5-AMP
895, d2dtiA2, 0.5464, 3.56, 0.079, 251, 89, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP PYROPHOSPHATE AND MN(2+)
896, d2dkgA2, 0.5463, 3.56, 0.079, 251, 89, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP PYROPHOSPHATE AND MG(2+)
897, p2eayB1, 0.5459, 1.30, 0.354, 67, 65, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS
898, d2deqA1, 0.5458, 3.44, 0.080, 251, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP K111G MUTATION
899, d2dz9A1, 0.5455, 2.54, 0.200, 88, 75, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH BIOTINYL-5 -AMP MUTATION D104A
900, d1x01B2, 0.5452, 2.08, 0.333, 95, 69, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ATP
901, d1wnlB2, 0.5448, 1.31, 0.354, 68, 65, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ADP
902, d2e41B2, 0.5444, 1.34, 0.354, 67, 65, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH THE REACTION PRODUCT ANALOG BIOTINOL-5 -AMP MUTATIONS R48A AND K111A
903, d1x2gA2, 0.5443, 1.34, 0.354, 66, 65, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI
904, d2e64A2, 0.5441, 3.92, 0.174, 251, 92, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATIONS R48A AND K111A
905, p4xtuB1, 0.5440, 3.92, 0.174, 251, 92, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR (N-({[(1R2S3R4R)-4-(6-AMINO-9H-PURIN-9-YL)-23- DIHYDROXYCYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS4S6AR)-2- OXOHEXAHYDRO-1H-THIENO[34-D]IMIDAZOL-4-YL]PENTANAMIDE)
906, d2dkgB2, 0.5438, 1.81, 0.348, 95, 66, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP PYROPHOSPHATE AND MG(2+)
907, p4xu0B1, 0.5437, 3.36, 0.140, 226, 86, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 73 THAT HAS A 2 -METHYL ON THE RIBOSE
908, d1oo4A_, 0.5437, 3.59, 0.078, 257, 90, P395S MUTANT OF THE P85 REGULATORY SUBUNIT OF THE N- TERMINAL SRC HOMOLOGY 2 DOMAIN OF PI3-KINASE COMPLEXED TO A PEPTIDE DERIVED FROM PDGFR
909, d1x2gB2, 0.5436, 3.59, 0.078, 257, 90, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI
910, d1x2hB2, 0.5435, 3.00, 0.100, 185, 80, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI COMPLEXED WITH LIPOIC ACID
911, d2dz9B1, 0.5432, 3.00, 0.100, 185, 80, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH BIOTINYL-5 -AMP MUTATION D104A
912, d2dveB1, 0.5432, 3.14, 0.118, 190, 85, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP MUTATION ARG51ALA
913, d2p0lA1, 0.5430, 1.38, 0.354, 67, 65, CRYSTAL STRUCTURE OF A LIPOATE-PROTEIN LIGASE A
914, d1wqwB2, 0.5430, 3.05, 0.100, 185, 80, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5-AMP
915, d1x2hC2, 0.5428, 1.37, 0.354, 66, 65, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI COMPLEXED WITH LIPOIC ACID
916, p4xtzB1, 0.5427, 3.29, 0.094, 205, 85, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 69 THAT HAS A FLUORINE IN PLACE OF THE RIBOSE 2 OH
917, d2dxuB1, 0.5427, 3.60, 0.102, 194, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH BIOTINYL-5 -AMP MUTATION R48A
918, d2dveA1, 0.5425, 2.99, 0.123, 216, 81, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP MUTATION ARG51ALA
919, p4xtvB1, 0.5423, 2.99, 0.123, 216, 81, MYCOBACTERIUM TUBERCULOSIS BIOTIN LIGASE COMPLEXED WITH BISUBSTRATE INHIBITOR 36 (N-({[(1R3S)-3-(6-AMINO-9H-PURIN-9-YL) CYCLOPENTYL]METHYL}SULFAMOYL)-5-[(3AS4S6AR)-2-OXOHEXAHYDRO-1H- THIENO[34-D]IMIDAZOL-4-YL]PENTANAMIDE)
920, d2dtoB2, 0.5423, 1.41, 0.354, 68, 65, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 COMPLEXED WITH ATP AND BIOTIN
921, d2djzB1, 0.5411, 3.51, 0.126, 182, 87, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP K111A MUTATION
922, d2hniA1, 0.5406, 3.73, 0.091, 192, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 K111A MUTATION
923, d2e65B1, 0.5402, 3.04, 0.074, 189, 81, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 MUTATION D104A
924, d2zgwB2, 0.5399, 3.04, 0.074, 189, 81, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH ADENOSINE AND BIOTIN MUTATIONS R48A AND K111A
925, d2e65A1, 0.5399, 3.32, 0.094, 205, 85, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 MUTATION D104A
926, d2e3yB1, 0.5399, 2.63, 0.063, 194, 79,  
927, d2dzcB1, 0.5395, 2.63, 0.063, 194, 79, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATION R48A
928, d2deqB1, 0.5394, 2.21, 0.338, 93, 68, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP K111G MUTATION
929, d1wq7B2, 0.5392, 3.37, 0.141, 223, 85, CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3
930, d1x2gC2, 0.5389, 3.58, 0.068, 230, 88, CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI
931, d2dzcA1, 0.5385, 3.20, 0.083, 233, 84, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATION R48A
932, p3fjpB1, 0.5361, 3.20, 0.083, 233, 84, APO STRUCTURE OF BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS
933, d1q89A_, 0.5356, 2.08, 0.286, 75, 70, CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN IBP39 (CUBIC CRYSTAL FORM)
934, p2eayA1, 0.5353, 3.56, 0.080, 238, 88, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS
935, d2e10B1, 0.5347, 3.41, 0.094, 202, 85, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATION R51A
936, p3fjpA1, 0.5345, 3.45, 0.106, 205, 85, APO STRUCTURE OF BIOTIN PROTEIN LIGASE FROM AQUIFEX AEOLICUS
937, d2e1hA1, 0.5345, 3.02, 0.112, 184, 80, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 K111G MUTATION
938, p3rkxA2, 0.5343, 3.30, 0.095, 202, 84, STRUCTURAL CHARACTERISATION OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE
939, d2ddzC_, 0.5339, 1.92, 0.294, 71, 68, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
940, d2ddzE_, 0.5324, 1.91, 0.348, 99, 66, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
941, d2ddzB_, 0.5313, 3.21, 0.107, 237, 84, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
942, d2ddzF_, 0.5306, 3.21, 0.107, 237, 84, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
943, p5mtnA_, 0.5304, 2.87, 0.165, 188, 79, MONOBODY MB(LCK_1) BOUND TO LCK-SH2
944, d2ddzA1, 0.5295, 3.01, 0.150, 182, 80, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
945, d2ddzD_, 0.5290, 2.84, 0.165, 188, 79, PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHI
946, d2e10A1, 0.5286, 2.15, 0.343, 93, 67, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATION R51A
947, p3v8jA2, 0.5285, 2.88, 0.177, 188, 79, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE
948, p6ck0A_, 0.5256, 2.90, 0.177, 188, 79, CRYSTAL STRUCTURE OF BIOTIN ACETYL COENZYME A CARBOXYLASE SYNTHETASE FROM HELICOBACTER PYLORI WITH BOUND BIOTINYLATED ATP
949, p6ck0B_, 0.5252, 2.97, 0.150, 183, 80, CRYSTAL STRUCTURE OF BIOTIN ACETYL COENZYME A CARBOXYLASE SYNTHETASE FROM HELICOBACTER PYLORI WITH BOUND BIOTINYLATED ATP
950, d1q88A_, 0.5229, 2.92, 0.162, 188, 80, CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN IBP39 (MONOCLINIC FORM)
951, p3l1aB1, 0.5132, 3.67, 0.080, 236, 87, STRUCTURAL ORDERING OF DISORDERED LIGAND BINDING LOOPS OF BIOTIN PROTEIN LIGASE INTO ACTIVE CONFORMATIONS AS A CONSEQUENCE OF DEHYDRATION
952, d2zgwA2, 0.5095, 2.93, 0.177, 188, 79, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH ADENOSINE AND BIOTIN MUTATIONS R48A AND K111A
953, d2e3yA1, 0.5095, 2.90, 0.177, 188, 79,  
954, p6aqqA2, 0.5076, 2.90, 0.177, 183, 79, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS BIOTIN PROTEIN LIGASE IN COMPLEX WITH INHIBITOR
955, d2dxtB1, 0.5066, 2.95, 0.162, 188, 80, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH ATP AND BIOTIN MUTATION D104A
956, p5sxbB1, 0.5063, 2.95, 0.162, 188, 80, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 23
957, d2ejgA1, 0.5052, 1.82, 0.354, 92, 65, CRYSTAL STRUCTURE OF THE BIOTIN PROTEIN LIGASE (MUTATION R48A) AND BIOTIN CARBOXYL CARRIER PROTEIN COMPLEX FROM PYROCOCCUS HORIKOSHII OT3
958, d2e64B2, 0.5037, 2.90, 0.177, 183, 79, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII MUTATIONS R48A AND K111A
959, d1oo3A_, 0.5033, 3.43, 0.099, 184, 81, P395S MUTANT OF THE P85 REGULATORY SUBUNIT OF THE N- TERMINAL SRC HOMOLOGY 2 DOMAIN OF PI3-KINASE
960, d1q87B1, 0.5027, 2.90, 0.177, 183, 79, CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN IBP39 (TETRAGONAL FORM)
961, d2dtiB2, 0.5009, 2.90, 0.177, 188, 79, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5 -AMP PYROPHOSPHATE AND MN(2+)
962, d2hniB1, 0.5008, 2.90, 0.177, 188, 79, CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 K111A MUTATION
